Registration for Index-Linked Annuities and Registered Market Value Adjustment Annuities; Amendments To Form N-4 for Index-Linked Annuities, Registered Market Value Adjustment Annuities, and Variable Annuities; Other Technical Amendments
Federal RegisterJul 24, 2024
Ask Donna
What actually matters in this document.
Text
SECURITIES AND EXCHANGE COMMISSION
17 CFR Parts 230, 232, 239, and 274
[Release No. 33-11294; 34-100450; IC-35273; File No. S7-16-23]
RIN 3235-AN30
Registration for Index-Linked Annuities and Registered Market Value Adjustment Annuities; Amendments To Form N-4 for Index-Linked Annuities, Registered Market Value Adjustment Annuities, and Variable Annuities; Other Technical Amendments
AGENCY:
Securities and Exchange Commission.
ACTION:
Final rule.
SUMMARY:
The Securities and Exchange Commission (“Commission”) is adopting rule and form amendments to provide a tailored form to register the offerings of registered index-linked annuities (“RILAs”). Specifically, the Commission is amending the form currently used by most variable annuity separate accounts, Form N-4, to require issuers of RILAs to register offerings on that form as well. To facilitate this amendment, the Commission is also amending certain filing rules and making other related amendments. These changes will implement the requirements relating to RILAs contained in the Consolidated Appropriations Act, 2023. The Commission is also extending the registration, filing, and disclosure requirements that the Commission is adopting for RILA offerings to the offerings of registered market value adjustment annuities. Further, the Commission is adopting other amendments to Form N-4 that will apply to all issuers that use that form. The Commission is applying to RILA and registered market value adjustment annuity advertisements and sales literature a current Commission rule that provides guidance as to when sales literature is materially misleading under the Federal securities laws. Finally, the Commission is adopting technical amendments to Forms N-6 and N-3 to correct errors from prior Commission rulemakings.
DATES:
Effective date:
This rule is effective September 23, 2024.
Compliance dates:
The applicable compliance dates are discussed in section II.J of this Release.
FOR FURTHER INFORMATION CONTACT:
Pamela Ellis, Alexis Hassell, Rachael Hoffman, Michael Khalil, Amy Miller, or Gregory Scopino, Senior Counsels; Bradley Gude, Branch Chief; Amanda Hollander Wagner, Senior Special Counsel; or Brian McLaughlin Johnson, Assistant Director, Investment Company Regulation Office, at (202) 551-6792; Min Oh, Senior Counsel; or Elizabeth Bentzinger or Michael Kosoff, Senior Special Counsels, Disclosure Review and Accounting Office, at (202) 551-6921, Division of Investment Management, Securities and Exchange Commission, 100 F Street NE, Washington, DC 20549-8549.
SUPPLEMENTARY INFORMATION:
The Commission is amending the following rules and forms:
1
15 U.S.C. 77a
et seq.
Commission reference
CFR citation
(17 CFR)
Securities Act of 1933 (“Securities Act”):
1
Rule 156
§ 230.156.
Rule 172
§ 230.172.
Rule 405
§ 230.405.
Rule 415
§ 230.415.
Rule 424
§ 230.424.
Rule 433
§ 230.433.
Rule 456
§ 230.456.
Rule 457
§ 230.457.
Rule 485
§ 230.485.
Rule 497
§ 230.497.
Rule 498A
§ 230.498A.
Regulation S-T:
Rule 313 of Regulation S-T
§ 232.313.
Rule 405 of Regulation S-T
§ 232.405.
Forms:
Form N-3
§ 239.17a and 274.11b.
Form N-4
§ 239.17b and 274.11c.
Form N-6
§ 239.17c and 274.11d.
Form 24F-2
§ 239.66 and § 274.24.
Table of Contents
I. Introduction and Background
A. Overview of RILA Features
B. Overview of Registered MVA Annuity Features
C. Current Registration Requirements for RILAs and Registered MVA Annuities
D. Developments and Analysis Informing Final Amendments
1. Investor Testing Informing Final Amendments
2. Analysis of Comments on Recurring Disclosure Topics Informing Final Amendments
E. Overview of the Final Amendments
II. Discussion
A. Use of Form N-4 for RILAs
B. Use of Form N-4 for Registered MVA Annuities
C. Contents of Form N-4
1. Front and Back Cover Pages (Item 1)
2. Overview of the Contract (Item 2)
3. Key Information Table (Item 3)
4. Principal Disclosure Regarding Index-Linked Options and MVA Options (Items 6 and 17)
5. Principal Risks of Investing in the Contract (Item 5)
6. Addition of Contract Adjustments and Other Amendments to Fee and Expense Disclosures (Items 4, 7, and 22)
7. Information About Contracts With Index-Linked and/or MVA Options (Item 31A)
8. Other Amendments and Provisions
9. Remaining Form N-4 Items
10. Inline XBRL
D. Option To Use a Summary Prospectus
1. Overview—Use of Summary Prospectus for Non-Variable Annuities
2. Initial Summary Prospectus
3. Updating Summary Prospectus
4. Online Accessibility of Contract Statutory Prospectus and Certain Other Documents Relating to the Contract
5. Other Requirements for Summary Prospectus and Other Contract Documents
E. Accounting (Items 16 and 26)
F. Filing and Prospectus Delivery Rules
1. Fee Payment Method and Amendments to Form 24F-2
2. Post-Effective Amendments and Prospectus Supplements
3. Prospectus Delivery
G. Communication Rules Applicable to Non-Variable Annuities Sales Literature (Rule 156)
2. Free Writing Prospectuses and Advertisements (Rules 433 and 482)
H. Existing Commission Letters
I. Technical Amendments to Forms N-3 and N-6
J. Effective and Compliance Dates
III. Other Matters
IV. Economic Analysis
A. Introduction
B. Baseline
1. Affected Parties
2. Current Regulatory Requirements
3. Market Practice
C. Benefits and Costs
1. Benefits
2. Costs
D. Effects on Efficiency, Competition, and Capital Formation
E. Reasonable Alternatives Considered
1. Creating an Entirely New Registration Form for RILAs
2. Alternatives to Specific Form N-4 Amendments
3. Limiting Scope of Structured Data Requirements
V. Paperwork Reduction Act
A. Rule 498A
B. Form N-4
C. Form 24F-2
D. Investment Company Interactive Data
VI. Regulatory Flexibility Act Certification Statutory Authority
I. Introduction and Background
The Commission is adopting rule and form amendments (“final amendments”) that are designed to help investors make informed decisions regarding RILAs. To modernize and enhance the registration and disclosure framework for RILAs, we are adopting amendments that will require offerings of RILAs to be registered on Form N-4, the registration form for most variable annuities, as well as adapt that form to accommodate RILAs. These amendments finalize rule and form amendments that the Commission proposed in September 2023.
2
2
See
Registration for Index-Linked Annuities; Amendments to Form N-4 for Index-Linked and Variable Annuities, Investment Company Act Release No. 35028 (Sept. 29, 2023) [88 FR 71088 (Oct. 13, 2023)] (“Proposing Release” or “proposal”). The Commission voted to issue the Proposing Release on September 29, 2023. The release was posted on the Commission website that day, and comment letters were received beginning the same day. The comment period closed on November 28, 2023. We have considered all public comment received through May 28, 2024. The comment letters on the Proposing Release are available at
https://www.sec.gov/comments/s7-16-23/s71623.htm.
The amendments implement Congress' directive to the Commission in Division AA, Title I of the Consolidated Appropriations Act, 2023 (“RILA Act”) to adopt a new registration form for RILAs within 18 months of enactment.
3
The RILA Act requires the Commission to design the form to ensure that a purchaser using the form receives the information necessary to make knowledgeable decisions, taking into account (1) the availability of information; (2) the knowledge and sophistication of that class of purchasers; (3) the complexity of the RILA; and (4) any other factor the Commission determines appropriate.
3
Publix Law 117-328; 136 Stat. 4459 (Dec. 29, 2022). The RILA Act provides that, if the Commission fails to adopt the form within 18 months of enactment, RILA issuers can begin registering RILA offerings on existing Form N-4.
The Commission's amendments will result in disclosure requirements for RILAs that are tailored to the particular characteristics of RILAs and comparable to variable annuity disclosure. We are also adopting related amendments to various Commission rules to effectuate the new disclosure requirements for RILAs and for further consistency in the registration, filing, and disclosure framework for RILAs compared to other similar annuity products. These amendments include, among other things: amendments permitting RILA issuers to use summary prospectuses; amendments that will result in the same requirements for RILAs and variable annuities in terms of updating the issuer's prospectus each year; and amendments that address how RILAs will register and pay for new shares, as well as other aspects of the registration and offering process. Furthermore, we are adopting amendments to extend the registration, filing, and disclosure approach we are adopting for RILAs to annuity contracts that offer fixed investment options and apply market value adjustments (“MVAs”) to amounts withdrawn from a fixed option before the end of the fixed option's term, where the offering is required to be registered with the Commission because of the MVA (“registered MVA annuities” and, collectively with RILAs, “non-variable annuities”).
4
We are additionally adopting other amendments to Form N-4 that will apply to all issuers that use that form, which are informed by the staff's historical experience in administering the form and relevant investor testing.
5
We are also adopting amendments that will apply a current Commission rule—which provides guidance as to when sales literature is materially misleading under the Federal securities laws—to RILA and registered MVA annuity advertisements and sales literature. Finally, we are adopting technical amendments to Forms N-6 and N-3 to update certain references used in those forms.
4
See
facing page of final Form N-4 in final Form N-4;
see also infra
footnote 16 and accompanying text (discussing the operation of MVAs); Section II.B (discussing the final amendments' requirement for registered MVA annuities to register on Form N-4). The term “non-variable annuities” distinguishes these annuities from variable annuities whose offerings are registered on Form N-4, in which investors allocate their purchase payments to a range of investment options—typically mutual funds—and the investor's account value changes depending on the performance of the investment options selected. We understand that this term is understood in the industry to refer to annuities other than variable annuities.
5
See infra
section I.D.1.
The Commission received comments on the proposal from a variety of interested parties, including life insurance companies, professional and trade associations, a public interest advocacy organization, and individuals.
6
Commenters broadly supported the proposal, including the proposed approach of requiring insurance companies to use Form N-4 to register RILA offerings, the amendments that would permit the use of summary prospectuses, and the amendments to filing and fee-payment rules. Some commenters suggested modifications and additions to the proposed approach, including changes to some of the specific disclosures that Form N-4 would require for RILAs. Others suggested we include registered MVA annuities (which currently, like RILAs, register on Forms S-1 and S-3) and certain other insurance products among those required to register on Form N-4. Some commenters also urged the Commission to extend rule 482 under the Securities Act, which addresses investment company advertising, to RILAs.
6
Some commenters raised topics that relate to various insurance product issues but not to the proposed rulemaking.
See, e.g.,
Comment Letter of the Committee of Annuity Insurers (Nov. 28, 2023) (“CAI Comment Letter”) (suggesting the Commission adopt amendments for life insurance products that are similar to RILAs). Another commenter sought clarification on topics related to variable and non-variable annuities that are unrelated to the proposed amendments. VIP Working Group Comment Letter (
e.g.,
seeking guidance on the application of Regulation D to certain offerings of variable and non-variable annuities). These comments are beyond the scope of this rulemaking.
After consideration of the comments received, we are adopting the proposed
amendments, with certain modifications. The final amendments retain each of the key elements of the proposed rules—the required registration of RILA offerings on Form N-4, the core aspects of the proposed disclosure requirements, the optional use of summary prospectuses by RILAs, the amendments to filing and fee-payment rules, and the amendments addressing materially misleading RILA sales literature. The resulting framework implements the RILA Act's mandate while making the RILA offering process similar to that for other insurance investment products, enhancing the information insurance companies disclose about RILAs, and extending certain antifraud guidance to RILA advertisements. However, we have modified certain proposed disclosure requirements and other aspects of the proposal to address the comments the Commission received. Additionally, the final amendments, in a change from the proposal and in response to comments received addressing the Commission's requests for comment about the registration of offerings of registered MVA annuities, will require these offerings to register on Form N-4. This, along with other amendments we are adopting extending the registration, filing, and disclosure framework we are adopting for RILAs to registered MVA annuities, and extending certain antifraud guidance to registered MVA annuity advertisements and sales literature, will result in greater uniformity in the regulation of non-variable annuities.
A. Overview of RILA Features
A RILA is one of several types of annuity contracts that insurance companies offer.
7
An investor in a RILA allocates purchase payments to one or more investment options under which the investor's returns (both gains and losses) are based at least in part on the performance of an index or other benchmark (collectively, “indexes”) over a set period of time (“crediting period”). A RILA may be offered on a standalone basis with various index-linked investment options (“index-linked options”) that investors may choose.
8
Alternatively, an insurance company may offer “combination” annuity contracts that provide index-linked options together with other investment options, such as mutual funds (“portfolio companies”) offered as investment options under a variable annuity (“variable options”) or fixed investment options, including fixed options subject to an MVA (“MVA options”).
9
The market for RILAs has grown significantly in recent years, with annual RILA sales of $47.4 billion in 2023 alone, 15% higher than in the prior year, and more than quintupling since 2017.
10
7
An annuity contract (“annuity” or “contract”) is a type of insurance product in which an investor makes a lump sum payment or a series of payments in return for future payments from the insurance company to meet retirement and other long-term financial goals.
8
Depending on the context, this Release uses the term “RILA” to refer collectively to stand-alone RILAs and the index-linked options available in a combination contract. When referring to the entity registering the RILA, we use the term “RILA issuer” or “insurance company.” One commenter suggested that the Commission should use a term other than “RILA,” as the term “registered” in “RILA” may serve to confuse investors because there are other investment products that are registered under both the Securities Act and the Investment Company Act of 1940 (the “Investment Company Act”) that do not include the term “registered” (
e.g.,
variable annuities, mutual funds, and exchange-traded funds).
See
Comment Letter of VIP Working Group (Nov. 10, 2023) (“VIP Working Group Comment Letter”). We continue to use the term “RILA” in the final amendments and in this Release for consistency with the RILA Act, as well as our understanding of common industry practice.
See, e.g.,
The Design and Regulatory Framework of Registered Index-Linked Annuities, ALI CLE Conference on Life Insurance Products 2022.
9
See
Updated Disclosure Requirements and Summary Prospectus for Variable Annuity and Variable Life Insurance Contracts, Investment Company Act Release No. 33814 (Mar. 11, 2020) [85 FR 25964 (May 1, 2020)] (“VASP Adopting Release”) at nn.4-5, 8, and accompanying text (describing the key features of variable annuity contracts and variable life insurance contracts (together, “variable contracts”)). An investor purchasing a combination contract, for example, may have the ability to allocate purchase payments under the contract to index-linked options; variable options that pass on the returns of mutual funds selected by the investor; and/or fixed account options for which the insurance company promises to pay a fixed and stated minimum rate of interest.
10
See
LIMRA, “LIMRA: Record-High 2023 Annuity Sales Driven by Extraordinary Growth in Independent Distribution,” news release (Mar. 12, 2024) (reporting 2023 RILA sales of $47.4 billion),
available at https://www.limra.com/en/newsroom/news-releases/2024/limra-record-high-2023-annuity-sales-driven-by-extraordinary-growth-in-independent-distribution/
(stating that high annuity sales were “largely due to broader engagement with independent distribution” and that “[r]ising interest rates have made annuities very attractive to a larger group of investors”). The fourth quarter of 2023 marked the first time RILA product sales surpassed variable annuity sales.
See also
LIMRA, “LIMRA Secure Retirement Institute: Total Annuity Sales Continued to Decline in 2017,” news release (Feb. 21, 2018) (reporting 2017 sales of structured annuity products,
i.e.,
RILAs, of $9.2 billion),
available at https://www.limra.com/en/newsroom/news-releases/2018/limra-secure-retirement-institute-total-annuity-sales-continued-to-decline-in-2017/.
RILAs are complex financial products that are sold to retail investors.
11
The Proposing Release describes some of the most prevalent features that contribute to this complexity, and that might make it challenging for an investor to assess the features, risks, and possible return profile of a RILA.
12
Under a RILA, the insurance company will credit positive or negative “interest” to the investor's contract value at the end of each crediting period. The amount credited is based, in part, on the performance of a specified index, rate, or benchmark (
e.g.,
the S&P 500).
13
One aspect of RILAs' complexity involves the various ways that interest may be credited, and how contract features that affect how interest is credited work together. The Proposing Release details RILAs' traditional bounded return structure, which typically limits investors' ability to participate in upside index performance (through features such as “cap rates” and/or “participation rates,” collectively “limits on gains”), and also limits investors' losses if the performance of the index goes down in value (through features such as “buffers” or “floors,” collectively “limits on losses”).
14
For many RILAs, the investor pays no direct or explicit ongoing fees and expenses under the RILA, and this is sometimes a feature communicated in RILA marketing materials. However, the RILA's bounded return structure requires investors to agree to tradeoffs that come with their own economic costs. That is, RILAs limit or reduce downside risk, but also limit upside performance. In exchange for some protection against losses if the index goes down in value, investors must also agree to contractual provisions limiting the gains they will receive if the index goes up in value. RILAs allow investors some ability to customize a level of risk with which they are comfortable.
15
But despite the bounded return structure, a RILA is not necessarily a low-risk investment product as the investor could lose a significant amount of money if the index performs poorly.
11
We understand that RILAs are predominantly sold by broker-dealers.
12
See
Proposing Release at Section I.A. This paragraph and the paragraphs that follow summarize the RILA features that Section I.A of the Proposing Release discusses.
13
Insurance companies typically choose indexes for the RILA contract where any gains in the value of the index do not include dividends paid on the securities that make up the index.
14
See
Proposing Release at paragraph accompanying n.10. A cap rate places an upper limit on an investor's ability to participate in the index's upside performance directly. A participation rate sets an investor's return to some specified percentage of the index's return. A buffer limits the investor's exposure to losses up to a fixed percentage. A floor places a lower limit on the investor's exposure to loss.
15
See infra
Section IV.B.3.
Charges and penalties for early withdrawals are another prevalent feature of RILAs. Investors can lose significant money if they withdraw their money early from an investment option or from the contract. This can arise in
several circumstances: (1) “surrender charges” that apply when an investor withdraws money from the contract within a certain period following the investor's last premium payment; (2) “interim value adjustments” (or “IVAs”), which adjust the investor's contract value if amounts are withdrawn (for instance, because of movements to a different investment option, movements out of the contract, or payment of certain benefits) from an index-linked option before the end of its crediting period;
16
and (3) a positive or negative MVA (collectively with IVAs, a “contract adjustment”) to the amount paid to the investor resulting from changes in interest rates if the investor partially or fully withdraws amounts from the contract or from certain fixed options.
17
Contract adjustments can occur in response to a number of contract transactions, such as a surrender, withdrawal, payment of the death benefit, or the start of annuity payments, and an investor could experience a negative contract adjustment even when the investor takes an otherwise permissible withdrawal, such as under a guaranteed living benefit. These adjustments also can negatively affect other values under the contract, such as the surrender value and death benefit. Moreover, these fees and adjustments are not always mutually exclusive.
18
As a result of these charges and penalties, the investor could lose a significant amount of money in a RILA investment, even if the index has a gain at the time of the withdrawal.
16
See id.
at n.11 and accompanying paragraph. The IVA will adjust the contract value based, generally, on a complex formula where the IVA may change daily and can be positive or negative.
17
MVAs can apply to RILAs, but, as discussed below, they also can apply to a fixed option available under an annuity contract.
See infra
Sections I.B and II.B.
18
See
Proposing Release at n.13 and accompanying paragraph. An investor may also be subject to income taxes and face a Federal income tax penalty if the investor withdraws money before a certain age.
In addition to the complexities that RILAs' bounded return structure and potential charges and penalties for early withdrawals entail, under virtually all RILA investments the insurance company may change or remove key features of index-linked options, such as the cap rates, floors, or even the index.
19
Also, RILA contracts typically state that an investor will be automatically renewed at the end of a crediting period into the same or substantially similar index-linked option, often with a new limit on gains. Furthermore, special tax rules generally apply to RILAs and other annuities, with both tax advantages and potential adverse tax impacts in certain circumstances.
20
19
See id.
at paragraph following n.13.
20
See id.
at n.14 and accompanying paragraph.
For all of these reasons, providing investors with key information is particularly important in the context of RILAs, since their features are typically complex and their risks may not be apparent or easily understood by prospective investors absent clear disclosure.
B. Overview of Registered MVA Annuity Features
Registered MVA annuities are annuity contracts that offer fixed investment options (where the insurance company promises to pay a fixed and stated minimum rate of interest) and apply MVAs to amounts withdrawn before the end of the fixed option's term.
21
The insurance company might apply an MVA, for example, when an investor withdraws money from the contract, transfers money among investment options, or annuitizes the contract. For these annuities, fixed options are either offered on their own or in a combination contract with index-linked options and/or variable options.
21
See
Proposing Release at Section II.H. The Proposing Release referred to registered MVA annuities as “registered MVAs.” For clarity and parallelism with the terms “RILA” and “variable annuity” (which also refer to different types of annuities), we refer to these products instead as “registered MVA annuities” in this Release.
As the Commission explained in the Proposing Release, RILAs and registered MVA annuities differ only with respect to the manner in which interest is calculated and credited.
22
Interest in a RILA contract is calculated and credited at the end of the crediting period based at least in part on the performance of an index or other benchmark, whereas interest in a registered MVA annuity is guaranteed and typically credited daily at a fixed rate.
23
Registered MVA annuities, however, like RILAs, apply contract adjustments upon withdrawals prior to term maturity. An investor in a RILA or registered MVA annuity therefore can lose money—and potentially a significant amount of money—due to a contract adjustment, and the way in which these adjustments are calculated may be complex.
22
See id.
One commenter stated that it largely agrees with this characterization.
See
CAI Comment Letter. No commenters disagreed with this characterization.
See also infra
section II.B (discussing more broadly the comments received on the Commission's request for comment in the Proposing Release on whether to require insurance companies to register the offerings of registered MVA annuities on Form N-4).
23
See id.; see also
CAI Comment Letter (agreeing with the Commission's statement in the Proposing Release that RILAs and registered MVA annuities differ only with respect to the manner in which interest is calculated and credited).
Existing disclosure for registered MVA annuities has many similarities to disclosure for RILAs. Like RILA disclosure, registered MVA annuity disclosure describes the operation of contract adjustments and the risks associated with such contract adjustments.
24
Disclosure for registered MVA annuities, like disclosure for RILAs and other annuity contracts, also describes basic annuity features (including, as for RILAs, information about surrender charges and applicable tax treatment) and the issuer's financial strength.
25
24
See
CAI Comment Letter.
25
See id.
C. Current Registration Requirements for RILAs and Registered MVA Annuities
RILAs are securities for purposes of the Securities Act.
26
Unlike variable annuity contracts for which the Commission has adopted a specific tailored registration form, insurance companies currently register offerings of RILAs on Securities Act registration Forms S-1 or S-3.
27
As the Proposing Release describes in detail and this Release summarizes, the current requirements for issuers offering RILAs and variable annuities (that is, the requirements prior to the amendments
the Commission is adopting in this Release) differ in many respects, both in terms of the disclosure issuers must provide and the registration process.
28
26
Under the final amendments, the final Form N-4 will not register the RILA or registered MVA annuity issuers themselves, only the offering of RILA or registered MVA annuity securities. Unlike separate accounts which register variable annuities, RILA and registered MVA annuity issuers are not investment companies, and thus need not register with the Commission as an investment company as separate accounts do. Index annuities that meet the requirements of section 989J of the Dodd-Frank Wall Street Reform and Consumer Protection Act (Pub. L. 111-203) or section 3(a)(8) of the Securities Act are treated as exempt securities for purposes of the Securities Act, but RILAs and registered MVA annuities do not fall within this exemption due, in large part, to the shifting of a significant level of investment risk from the issuer to the investor. RILAs and index-linked options, as used in this Release, refer only to those index annuities that are securities for the purposes of the Securities Act.
See, e.g.,
sections 101(a)(5) and (6) of the RILA Act. Similarly, registered MVA annuities and MVA fixed account options, as used in this release, refer only to annuities that are securities for the purposes of the Securities Act.
See infra
footnote 29 and accompanying text.
27
See, e.g.,
General Instruction I of Form S-1 (“This Form shall be used for the registration under the Securities Act of 1933 (`Securities Act') of securities of all registrants for which no other form is authorized or prescribed”). The registration forms for variable annuity contracts are Form N-3 (for variable annuity separate accounts structured as management investment companies) and Form N-4 (for variable annuity separate accounts structured as unit investment trusts).
See
Proposing Release at n.6 and accompanying text. In this Release, we focus only on Form N-4 and not Form N-3, because Form N-4 is the registration form identified in the RILA Act and the form used to register most variable annuity contracts.
28
See
Proposing Release at Section I.B.
Registered MVA annuities also are securities for purposes of the Securities Act. They are securities because the MVA feature imposes certain investment risks on purchasers.
29
Like RILA offerings, offerings of registered MVA annuities are currently registered on Forms S-1 or S-3. While this section of the Release discusses the registration requirements for RILAs, the current registration requirements for registered MVA annuities are the same as those for RILAs and present the same considerations.
29
See
section 3(a)(8) of the Securities Act and 17 CFR 230.151;
see also SEC
v.
Variable Annuity Life Insurance Co. of America,
359 U.S. 65, 77 (1959).
In general, the disclosure requirements of Forms S-1 and S-3 are not specifically tailored to particular kinds of securities given the wide range of securities offerings that issuers can register on these forms.
30
Forms S-1 and S-3 thus do not include specific line-item requirements addressing disclosures about RILAs and their complex features. These forms also require issuers to disclose information about the offering itself as well as extensive information about the registrant issuing the securities that a RILA investor may view as less important than information about the contract's features. Domestic registrants also must include financial statements prepared in accordance with U.S. generally accepted accounting principles (“GAAP”).
31
30
See
Proposing Release at nn.15-17 and accompanying paragraph.
31
See
17 CFR 210.4-01(a)(1) (stating that financial statements filed with the Commission which are not prepared in accordance with GAAP will be presumed to be misleading or inaccurate unless the Commission has otherwise provided).
See also
Proposing Release at n.20.
The Form N-4 disclosure requirements for variable annuities, on the other hand, are tailored for variable annuities.
32
Form N-4's disclosure requirements are designed to provide investors with key information relating to a variable contract's provisions, benefits, and risks, along with information about the insurance company and the offering. In addition, rule 498A and Form N-4 together implement a layered disclosure approach for variable annuities by permitting insurance companies and others to use a summary prospectus framework for variable annuities while making the more-detailed statutory prospectus, as well as the contract's statement of additional information (“SAI”), available online. Form N-4 also provides a limited exception for insurance companies to file financial statements prepared in accordance with statutory accounting principles (“SAP”), referred to as “statutory requirements” in the form instructions, rather than GAAP.
33
Structured data requirements for RILA and variable annuity disclosure also differ.
34
32
See
Proposing Release at nn.18-20 and accompanying paragraph.
33
Specifically, insurance companies, which act as the depositors of variable annuity separate accounts registered on Form N-4, may use SAP financials solely when the insurance company does not otherwise prepare GAAP financial statements or GAAP financial information for use by a parent in the parent's Securities Exchange Act of 1934 (“Exchange Act”) reports or the parent's registration statements filed under the Securities Act.
See id.
at n.20 and accompanying text.
34
See
Proposing Release at n.25 and accompanying text, and text following n.26.
The Proposing Release also details key differences in the current registration process for RILAs versus variable annuities.
35
While insurance companies pay registration fees at the time they register the offer and sale of RILA securities, a separate account that registers under the Investment Company Act and offers variable annuity securities on Form N-4 pays registration fees based on the net issuance of securities, no later than 90 days after each fiscal year end.
36
Updates to RILA offering registration statements occur by filing a post-effective amendment to a Form S-1 registration statement (which must be declared effective, typically by staff acting pursuant to delegated authority) or by the filing of the insurance company's annual report on Form 10-K containing audited financial statements, which operates as a post-effective amendment to a registration statement on Form S-3.
37
In contrast, a variable annuity registration statement on Form N-4 may be updated by filing an immediately-effective post-effective amendment under rule 485. This permits the efficient registration of continuous offerings of variable annuities.
35
See id.
at paragraphs accompanying nn.21-26.
36
See id.
at nn.21 and 26 and accompanying text.
37
See id.
at nn.22-24 and accompanying text.
D. Developments and Analysis Informing Final Amendments
1. Investor Testing Informing Final Amendments
In addition to the RILA Act's requirements described above, the RILA Act also requires the Commission to engage in investor testing as part of its rulemaking process and to incorporate the results of the testing in the design of the new registration form for RILAs, with the goal of ensuring that key information is conveyed in terms that a purchaser can understand. Consistent with the RILA Act, the Commission received feedback on individuals' comprehension and views on RILA disclosure through investor testing. Specifically, the Commission's Office of the Investor Advocate (“OIAD”) conducted two rounds of qualitative interviews with a mix of investors across demographic characteristics, locations, and levels of financial literacy who either already owned annuities or had expressed interest in investing in an annuity product. The results of the two rounds of qualitative testing then helped inform a round of quantitative testing with approximately 2,500 participants.
This investor testing, which the Proposing Release and a report describing investor testing that OIAD conducted describe in detail, helped us to identify areas of Form N-4 that we proposed to amend to help ensure that a RILA purchaser receives key information that the purchaser is able to understand.
38
Feedback from both rounds of qualitative interviews generally showed that the interview participants did not have much, if any, familiarity with RILAs. Furthermore, interviews in both rounds illustrated that many participants struggled to understand the details of the RILA contract presented in sample disclosure that could appear in select rows of the “Key Information Table” (or “KIT”) in RILA registration statements. Participants indicated significant confusion about the features and fees associated with RILAs, and often cited certain specific terminology, such as “index option,” “interim value adjustment,” “buffer,” and “investment term,” as confusing to them. Although interview participants may not have been able to understand RILA features and economic tradeoffs fully after reviewing sample KIT disclosure, some were able to identify certain potential drawbacks and explain certain aspects of RILA contracts following their review of this sample disclosure.
38
Office of Investor Advocate Division, Investor Testing Report on Registered Index-Linked Annuities (OIAD Working Paper 2023-01), (Sep. 2023) (“OIAD Investor Testing Report”)
available at https://www.sec.gov/files/rila-report-092023.pdf; see also
Proposing Release at Section I.C.
The investor testing successfully identified a range of barriers to investor understanding of RILAs and associated disclosure. However, with few exceptions, the variations in RILA disclosures presented to participants did not result in significant improvements in investor
comprehension.
39
The Commission incorporated the investor testing results in its design of the proposed Form N-4 amendments, endeavoring to give particular attention to: (1) disclosure variations that resulted in statistically significant improvements in investor comprehension (specifically, the use of Q&A KIT format); and (2) areas of identified investor confusion while leveraging existing disclosure requirements.
40
Because investor testing did not, for the most part, provide persuasive evidence of superior disclosures, the Commission proposed largely to utilize the existing Form N-4 disclosures that have been developed over time, and with which staff, investors, and RILA issuers are already familiar.
39
See
Proposing Release at n.58 and accompanying text, and paragraphs following n.58.
40
See id.
(stating that the Q&A KIT format demonstrated a statistically significant, albeit quantitatively small, improvement over the non-Q&A KIT format, and stating that investor testing successfully identified a range of barriers to investor understanding of RILAs and associated disclosures).
The Commission sought comment on this proposed approach, and it also sought comment throughout the Proposing Release on specific areas for improvement that would aid investor comprehension. Furthermore, the Commission requested specific input from the retail investor community through a short feedback flyer seeking input on their experiences with annuities generally and RILAs specifically (“Feedback Flyer”).
41
Commenters did not generally address the investor testing that informed the proposed approach, and the Commission received no Feedback Flyer responses.
42
41
See id.
at n.59 and accompanying text;
see also
Feedback Flyer
available at https://www.sec.gov/files/rules/proposed/2023/rila-feedback-flyer.pdf.
42
One commenter, while not commenting on the investor testing substantively, discussed the RILA trends that the OIAD Investor Testing Report described, as discussed in more detail below.
See infra
footnote 305 and accompanying text.
The Commission's Investor Advocate also provided comments discussing the investor testing process and supporting the proposed rules, stating the belief that the proposed RILA registration form would make it easier for investors to understand RILAs.
43
The Investor Advocate stated that the proposed rule's registration form would be more helpful for investors than the forms currently used for RILA registration. The Investor Advocate also stated that modified Form N-4 “is likely to improve investor comprehension related to the features, costs, and risks of RILAs.”
43
See
Comment Letter of Cristina Martin Firvida, SEC Investor Advocate (Dec. 22, 2023) (“Investor Advocate Comment Letter”).
In addition to these statements, the Investor Advocate suggested areas in which “more work can be done to help investors make well-informed decisions about RILAs and other complex financial products.” The Investor Advocate stated that the proposed rule's registration form for RILAs, while informed by investor testing efforts, was not tested itself, and that this represents a missed opportunity in the Commission's rulemaking process. While the RILA Act directed the Commission to “engage in investor testing” when developing the registration form for RILAs, the Act did not require that the entirety of the form be investor tested, and doing so would have been impracticable under the circumstances due to the statutory rulemaking timeline, taking into account the time it takes to develop and execute well-designed and probative investor testing. As a result, investor testing efforts necessarily entailed strategic choices about topics on which to focus. These timing factors also required consideration of disclosure areas where maximizing comprehension could be particularly impactful.
For these reasons, investor testing of RILA registration statement disclosure focused primarily on a sample of RILA-related disclosures that could appear in the KIT, if Form N-4 were amended to address RILA offerings.
44
As discussed in the Proposing Release and below, the KIT—which provides summary disclosure in a specific sequence and in a standardized presentation—appears in variable annuity prospectuses, and the Commission proposed to include KIT disclosure in RILA prospectuses.
45
The required ordering, contents, and standardization of KIT disclosure made the sample RILA-related disclosure especially amenable to investor testing, as these structural aspects made it possible to test variations on required disclosure elements easily. The summary disclosure in the KIT covers core features and risks of the annuity that the registration statement describes, with more detail elsewhere in the registration statement. For this reason, using the KIT to determine areas where investor comprehension could be enhanced was particularly impactful, as knowledge gained from this investor testing could be applied to disclosure in multiple other areas of the registration statement. The KIT is one of the first disclosure items that appears not only in the statutory prospectus, but also in the summary prospectus for issuers that choose to use summary prospectuses. It is also formatted in a manner that is designed to enhance readability. The investor testing therefore focused on disclosure that could have maximal impact in terms of investor attention.
44
See
OIAD Investor Testing Report.
45
See
Proposing Release at Section II.B.2;
see also
Item 2 of current Form N-4 (current KIT requirements);
infra
Section II.C.3 (describing amendments to current KIT requirements).
While the Investor Advocate states that there is no “data to indicate whether the registration form effectively conveys the information necessary for investors to make well-informed investment decisions about RILAs,” the sample KIT disclosure did include topics that comprise the primary features and risks of RILAs, and the investor testing did identify aspects of this disclosure that investors may find particularly challenging to understand. This in turn provided helpful input in identifying the disclosure areas where clear language, and enhanced focus in the registration statement, could help investors understand unique, and often complex, aspects of RILAs. We discuss these disclosure areas in more depth in Section II below.
The Investor Advocate further stated that, although the Commission has “made commendable efforts to improve the clarity and conciseness of disclosure provided to investors within the existing regulatory disclosure infrastructure,” new and innovative approaches to disclosure are encouraged to significantly reduce investors' disclosure burden. The Investor Advocate encouraged the Commission “to explore more significant departures from the status quo in the realm of disclosure related to RILAs and other complex products.” We agree that exploring innovative disclosure approaches could enhance the investor experience for investors in complex products.
46
A wholesale reimagining of disclosure for funds and other registered investment products, however, is outside of the scope of this rulemaking and impracticable in the context of this rulemaking given statutory time constraints. We also believe that requiring RILAs to use Form N-4, and adapting the current disclosure approach for variable annuities to RILAs, is consistent with the RILA Act's mandate as discussed below.
47
Furthermore, we agree that continuing to test specific Commission-mandated disclosures, including to assess how investors respond to these disclosures, as well as continuing to analyze the Commission's approach to its disclosure regime generally, are important complements to our regulatory program. We encourage Commission staff to incorporate these investor testing principles not only in the course of recommending new disclosure requirements, but also in continuing to develop its investor testing program outside of the confines of particular rulemaking actions.
46
The Commission is continually considering ways to enhance disclosure and the retail investor experience.
See, e.g.,
Request for Comment on Fund Retail Investor Experience and Disclosure, Investment Company Act Release No. 33113 (June 5, 2018) [83 FR 26891 (June 11, 2018)] (“Investor Experience RFC”).
47
See infra
Section II.A.
In addition to investor testing focused specifically on sample RILA disclosure, our final amendments—and the current disclosure requirements in Form N-4 that we are building upon—also draw on the Commission's past investor testing efforts, outreach, and other empirical research concerning investors' preferences. This includes, for example, information about summary content and layered disclosure approaches.
48
The Commission has historically received feedback showing that investors generally prefer concise, layered disclosure.
49
Investors participating in certain past quantitative and qualitative investor testing initiatives on the Commission's behalf have also expressed preferences for, wherever possible, the use of a summary containing key information about an investment product or service written in clear, concise, and understandable language and presented in an accessible format.
50
Each of these sources of evidence of investor preferences, understanding, and behaviors in response to disclosures specific to RILAs and other investment products more generally has provided important context and support for the final amendments' approach to RILA disclosure.
48
See
Updated Disclosure Requirements and Summary Prospectus for Variable Annuity and Variable Life Insurance Contracts, Investment Company Act Release No. 33286 (Oct. 30, 2018) [83 FR 61730 (Nov. 30, 2018)] (“VASP Proposing Release”) at paragraphs accompanying nn.38-43.
49
See, e.g.,
Investor Experience RFC;
see also
Proposing Release at n.61 (discussing feedback in comments on the Investor Experience RFC, generally showing that retail investors prefer concise, layered disclosure and feel overwhelmed by the volume of information they currently receive, and reflecting a preference for shorter summary disclosures, with additional information available online or upon request).
50
See
Proposing Release at n.62.
2. Analysis of Comments on Recurring Disclosure Topics Informing Final Amendments
The proposed amendments collectively were designed to provide investors with disclosures tailored to RILAs and to highlight key information about these complex products, building on the Commission's layered disclosure framework for variable annuities. The proposed requirements were developed with consideration for clear, concise, and understandable disclosure about RILA features and risks. Certain commenters expressed concern, however, that the proposed disclosure requirements included “excessive repetition,” especially with respect to certain topics.
51
Commenters stated that excessive repetition adds to the length of the prospectus without commensurate value to investors, obscures new information that investors should be focusing on, and is not consistent with plain English principles. In addition to general concerns about repetition in the proposed requirements, commenters expressed concerns about specific disclosure areas where they viewed the proposed requirements as resulting in particularly repetitive disclosure.
52
51
See
CAI Comment Letter;
see also
Comment Letter of Ova Datop (Oct. 25, 2023) (“Datop Comment Letter”).
52
See
CAI Comment Letter (discussing proposed maximum potential loss disclosure requirements); Datop Comment Letter (discussing proposed risk warnings).
We agree that no disclosure should be repeated simply for the sake of repetition, and we also agree that repetition in disclosure can have negative effects on investor understanding as commenters expressed. As discussed below, the final form amendments take commenters' concerns into account. There are certain areas where the final amendments reduce the discussion of the same or similar topics in multiple locations, where this reduction could appropriately be made while continuing to promote the goal of highlighting key information about RILAs and enhancing understanding of RILA features and risks.
53
53
See, e.g.,
discussion below about changes from the proposal to remove some of the numeric examples illustrating maximum potential loss that, as proposed, would have appeared in multiple locations throughout the prospectus (at
infra
Sections II.C.2 and II.C.4).
The final amendments, like the proposal, continue to incorporate the principle of layered disclosure. Layered disclosure aims to provide investors with key information relating to an investment's features, benefits, and risks in a concise and reader-friendly presentation, with more-detailed or technical information available to those investors who find the information valuable. The use of layered disclosure means that the disclosure requirements we are adopting necessarily address particular topics in more than one location in the registration statement. Where this occurs, the disclosure requirements intentionally include summary disclosure in the first “layer,” and additional details building on the summary in the second “layer.”
54
This approach is designed to help investors with different informational needs access the information that will be most useful to them.
54
For example, the KIT will put investors on notice of the existence and general impact of a contract adjustment, while other disclosure later in the prospectus discusses contract adjustments in detail, including a brief discussion in simple terms of the manner in which contract adjustments are determined.
See
Items 3 and 7(e) of final Form N-4. If an investor wants more details about the specific formulas that are used to calculate contract adjustments, this information is available in the SAI.
See
Item 22(d) of final Form N-4.
Additionally, and as discussed in more detail below, there are certain disclosure requirements in Form N-4 as amended that address similar topics as other disclosure requirements, where investors could benefit from considering these topics in several different contexts. This also reflects that, except with respect to certain disclosure items that are designed to be read in tandem, RILA investors may not necessarily read a prospectus from cover to cover, but instead may choose to read sections of the prospectus about topics where they are seeking particular information.
55
For instance, in addition to the numeric examples illustrating maximum potential loss, the final disclosure requirements include narrative discussion of a RILA's maximum potential loss from poor index performance in several locations in the prospectus. This is intentional. RILAs are frequently marketed as a product that will protect against investment losses through loss-limiting features. Information about maximum potential loss is relevant in the contexts of the contract overview and KIT, as well as in considering principal risks and more in-depth disclosure about the investment options a contract offers.
56
Therefore, disclosure that is designed to enhance understanding of this aspect of a RILA contract, in varying contexts, will help investors make informed decisions that take into account this often-misunderstood aspect of investing in a RILA.
57
55
As discussed below, we anticipate that investors will read the Overview and KIT sections of the prospectus together.
See infra
Sections II.C.2 and II.C.3.
56
See, e.g., infra
Sections II.C.2, II.C.3, II.C.4, and II.C.5.
57
See, e.g.,
Proposing Release at Section I.C.
E. Overview of the Final Amendments
We are adopting rule and form amendments that modernize and enhance the registration, filing, and disclosure framework for RILAs by adapting the existing framework that is familiar to investors and issuers for variable annuity separate accounts to accommodate RILAs. The final amendments implement the RILA Act's mandate.
•
Use of Form N-4 to Register RILA Offerings.
As proposed, we are amending Form N-4 so that issuers seeking to register the offering of RILAs must use that form. To accommodate this, we are also adopting amendments to Form N-4 that specifically address the features and risks of RILAs, with certain modifications from the proposal in consideration of comments received. These modifications address, among other things, disclosure relating to the potential for investment loss from an investment in a RILA, current limits on index gains, and guaranteed limits on index losses or gains. Further, because the insurance company will register the offering of a RILA on Form N-4 under the final amendments, it will be subject to the requirements in the form related to financial statements. This includes, as proposed, the form instruction that currently permits variable annuity issuers to file insurance company SAP financial statements in certain circumstances. Generally as proposed, the final amendments require RILA issuers to tag certain information in Inline eXtensible Business Reporting Language (“Inline XBRL”) format.
•
Use of Form N-4 for Registered MVA Annuities.
In a change from the proposal, the final amendments extend the registration, filing, and disclosure requirements we are adopting for RILA offerings to offerings of registered MVA annuities on Form N-4.
•
Form N-4 Amendments for Variable Annuity Offerings.
We are adopting form amendments that are applicable to offerings of variable annuities. These amendments are informed by the staff's historical experience in administering the form and respond to observations from investor testing relevant to variable annuity offerings.
58
We are adopting these amendments generally as proposed, with some modifications in consideration of comments received.
58
See id.
at n.63 and accompanying paragraph.
•
Summary Prospectus.
Consistent with the inclusion of RILAs on Form N-4 and generally as proposed, we are adopting amendments that permit RILA issuers to make use of the summary prospectus framework available to variable annuity registrants on Form N-4. In a modification from the proposal, issuers of registered MVA annuities also will be able to use the summary prospectus framework, consistent with the inclusion of registered MVA annuities on Form N-4.
•
Updates to the Filing Rules.
To accommodate RILA and registered MVA annuity offering registrations on Form N-4, we are adopting amendments that require issuers of these securities to pay fees in arrears on Form 24F-2, as well as amendments to address RILAs and registered MVA annuities in the rules that variable annuities use to file post-effective amendments and to update prospectuses. We are adopting these amendments as proposed with conforming amendments to address the inclusion of registered MVA annuities on Form N-4.
•
Communications Rules Applicable to Non-Variable Annuities.
The final amendments, as proposed, require RILA issuers to comply with rule 156, which provides guidance as to when sales literature is materially misleading under the Federal securities laws. We are adopting conforming amendments to rule 156 to address the inclusion of registered MVA annuities on Form N-4. Additionally, in a change from the proposal, we are also making a technical amendment to rule 433 to allow those non-variable annuity issuers that can meet the rule's conditions to continue to use a free writing prospectus without it needing to be preceded or accompanied by a prospectus that satisfies the requirements of section 10 of the Securities Act.
II. Discussion
A. Use of Form N-4 for RILAs
Most variable annuity issuers register variable annuity offerings on Form N-4, which the Commission designed to provide investors with product-specific information about annuity contracts, and which utilizes the summary prospectus layered disclosure framework the Commission adopted in 2020 for variable contracts.
59
As proposed, we are requiring insurance companies to register RILA offerings on Form N-4, leveraging the form's existing insurance-product specific disclosures and framework while incorporating revised disclosures informed by investor testing and staff experience to assist investors in making knowledgeable decisions about RILA offerings.
60
59
Variable annuities register on Form N-3 if they are issued by separate accounts that are organized as management investment companies. However, most variable annuities are issued by separate accounts that are organized as unit investment trusts and therefore use Form N-4.
See
Proposing Release at n.20. The separate account established by the sponsoring insurance company is the legal entity that registers its securities. Separate accounts are typically registered as investment companies under the Investment Company Act.
See
section 2(a)(37) of the Investment Company Act. The Commission first adopted the registration form for variable annuities approximately 40 years ago.
See
Registration Forms for Insurance Company Separate Accounts that Offer Variable Annuity Contracts, Investment Company Act Release No. 14575 (June 14, 1985) [50 FR 26145 (June 25, 1985)] (“Forms N-3 and N-4 Adopting Release”).
60
See
the facing page of final Form N-4 (Form N-4 is “to be used by insurance companies to register the offerings of registered index-linked annuity contracts . . . under the Securities Act”). Accordingly, following the compliance date for the final amendments, insurance companies will no longer be permitted to register RILA offerings on Forms S-1 or S-3, as they do today.
Commenters broadly supported registering RILA offerings on Form N-4.
61
A number of commenters agreed that proposed Form N-4 would provide RILA investors with more meaningful and helpful disclosures as compared to the disclosures required on the registration forms currently used by RILAs that are not tailored to RILA features.
62
Some commenters emphasized that the proposed disclosures about the contract and its features and the incorporation of Form N-4's layered disclosure would be of particular benefit to investors.
63
Additionally, one commenter suggested that requiring RILAs to register on forms that are not tailored for RILA offerings has impeded the ability of RILA investors to find and understand the information that is most relevant to their investment decisions, and has also slowed product development and impeded the entry of new issuers to the RILA marketplace.
64
Commenters suggested that investors also would benefit from registering RILAs and variable annuity contracts on the same registration form because it would facilitate the ability of investors to
compare and contrast different RILA and variable annuity offerings.
65
One of these commenters also stated that, by leveraging the experience of investors, registrants, and Commission staff with the existing Form N-4 framework, the proposal would help achieve greater regulatory uniformity, simplify the registration of RILA and variable annuity combination products, and reduce the burdens insurance companies face in preparing RILA registrations.
66
61
See
Comment Letter of the American Council of Life Insurers (Nov. 28, 2023) (“ACLI Comment Letter”); Comment Letter of Better Markets, Inc. (Nov. 28, 2023) (“Better Markets Comment Letter”); CAI Comment Letter; Comment Letter of Gainbridge Life Insurance Company and Delaware Life Insurance Company (Nov. 28, 2023) (“Gainbridge Comment Letter”); Investor Advocate Comment Letter; Comment Letter of the Insured Retirement Institute (Nov. 28, 2023) (“IRI Comment Letter”). No commenters disagreed with the proposed use of Form N-4 to register RILA offerings.
62
See id.
One of these commenters stated that it would object to the inclusion on Form N-4 of additional company-related disclosures applicable to registrations under Forms S-1 and S-3 because those disclosures are less relevant to RILA offerings.
See
CAI Comment Letter.
63
See
Better Markets Comment Letter; CAI Comment Letter; Gainbridge Comment Letter; IRI Comment Letter; Investor Advocate Comment Letter.
64
See
IRI Comment Letter.
65
See
CAI Comment Letter; Gainbridge Comment Letter.
66
See
CAI Comment Letter.
After considering these comments, we are adopting a registration framework that requires the registration of RILA offerings on Form N-4 as proposed. Consistent with the views expressed by commenters, registering RILA offerings on final Form N-4 should benefit investors by requiring tailored disclosures relevant to RILA investors and facilitating the ability of investors to compare similar products. Registering RILA offerings on final Form N-4 also provides greater regulatory uniformity, reducing burdens for both RILA issuers in preparing RILA registration statements and Commission staff in reviewing them.
Finally, one commenter requested the Commission provide guidance regarding the ability of certain RILA contracts currently registered on Form S-3 to rely on 17 CFR 240.12h-7 (“rule 12h-7”) following their transition to Form N-4.
67
Rule 12h-7 provides an exemption from Exchange Act reporting applicable to insurance companies with respect to certain securities, including RILAs, that are registered under the Securities Act and regulated under State law. In order to be eligible for this exemption, among other conditions, the issuer of the securities must take steps reasonably designed to ensure that a trading market for the securities does not develop, including requiring written notice to, and acceptance by, the issuer prior to any assignment or other transfer of the securities and reserving the right to refuse assignments or other transfers at any time on a non-discriminatory basis (“anti-assignment clause”).
68
One commenter suggested that there are a number of RILA contracts that do not have an anti-assignment clause because the issuing insurance companies have chosen to register the offerings on Form S-3 and therefore have not relied on rule 12h-7 because Form S-3 is only available to issuers subject to Exchange Act reporting requirements. This commenter suggested that unilaterally adding an anti-assignment clause now to already-issued contracts previously registered on Form S-3 would violate State law. Now that RILA offerings will be registered on Form N-4, this commenter suggested that issuers of these RILA contracts would like to rely on rule 12h-7. As the Commission explained in rule 12h-7's adopting release, the anti-assignment clause requirement is an important condition of the exemption from Exchange Act reporting because it ensures that the issuer will take steps reasonably designed to preclude the development of a trading market in the contracts.
69
Although all issuers relying on rule 12h-7 are required to take such reasonable steps, rule 12h-7 provides that an anti-assignment clause is not required where it is prohibited by State law.
70
Under that rule, where an issuer of a RILA contract that is currently registered on Form S-3 is seeking now to rely on rule 12h-7, that issuer would not need to modify the contract to include an anti-assignment clause where including such a clause is prohibited by State law.
71
Whether including an anti-assignment clause is prohibited under State law is based on the facts and circumstances and laws of each applicable State.
67
See
CAI Comment Letter. Under the final amendments, RILAs that have previously registered offerings of securities on Forms S-1 or S-3 prior to the Compliance Date will need to file a post-effective amendment to their registration statement pursuant to rule 485(a) by May 1, 2026 using Form N-4.
See infra
Section II.J.
68
See
rule 12h-7(e).
69
See
Indexed Annuities and Certain Other Insurance Contracts, Exchange Act Release No. 34-59221 (Jan. 8, 2009) [74 FR 3138 (Jan. 16, 2009)] (“12h-7 Adopting Release”) at Section III.B.2.
70
See
rule 12h-7(e). Consistent with rule 12h-7(e), by “State law” we mean the law of any State or action of the insurance commissioner, bank commissioner, or any agency or officer performing like functions of any State.
71
Of course, an issuer seeking to rely on rule 12h-7 would also need to comply with the rule's other requirements, including that it takes steps reasonably designed to ensure that a trading market for the securities does not develop.
See
rule 12h-7(e).
B. Use of Form N-4 for Registered MVA Annuities
We are adopting amendments to require the offerings of registered MVA annuities to be registered on Form N-4 and, as a result, extend the registration and disclosure requirements we are adopting for RILAs to registered MVA annuities. Similar to the amendments we are adopting for RILAs, these amendments will benefit investors by providing a tailored disclosure regime with clear, relevant, and layered disclosure. Further, by including registered MVA annuities on Form N-4 along with RILAs and variable annuities, investors should benefit from being able to compare and contrast different types of annuity contracts. Both issuers and investors will also benefit by leveraging their existing familiarity with the form.
In the Proposing Release, we solicited comment on whether to require insurance companies to register the offerings of registered MVA annuities on Form N-4, and we detailed the various changes to disclosure that would be necessary to accommodate this change.
72
Commenters that spoke to this issue supported registering offerings of registered MVA annuities on Form N-4,
73
suggesting that investors in registered MVA annuities would benefit from a comparable disclosure regime that provides clear, relevant, and layered disclosure.
74
One of these commenters stated that registered MVA annuities are a significantly simpler product than RILAs and present a subset of identical risks to investors as RILAs.
75
Commenters also stated that many of the disclosures that would be required for RILAs on Form N-4 would also be appropriate for registered MVA annuities, such as disclosures on the operation of contract adjustments and the risks associated with such contract adjustments.
76
One commenter stated that only minor modifications to the disclosures for RILAs would be required to reflect that an investor's return in a RILA is based on the performance of an index while the return of a registered MVA annuity is based on a stated rate of interest.
77
Further, this commenter stated that registered MVA annuities
may be offered in combination products with variable annuities and/or RILAs that will be registered on Form N-4. Given that such products will have one prospectus, this commenter stated that investors, issuers, and the Commission would benefit from such products registering on Form N-4, rather than registering on both Form N-4 (for the variable annuity or RILA component) and Form S-1 or Form S-3 (for the registered MVA annuity component).
72
Proposing Release at Section II.H.
73
No commenters opposed using Form N-4 to register MVA annuity offerings, although one commenter urged that using Form N-4 should be optional in certain circumstances discussed below.
See infra
footnote 79. One commenter stated that contingent deferred annuities (“CDAs”) could be considered covered by the RILA Act and insurers should be permitted to use Form N-4 for these annuities under the provision in that Act allowing insurers to use Form N-4 for RILAs if the Commission does not provide a new registration form for RILAs by the statutory deadline.
See
VIP Working Group Comment Letter. We disagree. The RILA Act covers annuities that, among other things, have returns based on the performance of a benchmark index and may be subject to a market value adjustment if amounts are withdrawn before the end of the period during which that market value adjustment applies. CDA lifetime payment guarantees are not based on a benchmark or index and are not subject to such market value adjustments. Additionally, because CDAs are substantially different products than RILAs, significant modifications to Form N-4 would be required to accommodate offerings of CDAs.
74
See
CAI Comment Letter; IRI Comment Letter; VIP Working Group Comment Letter.
75
CAI Comment Letter.
76
See
IRI Comment Letter; CAI Comment Letter.
77
CAI Comment Letter.
At the same time, some commenters generally stated that registered MVA annuities should be permitted, but not required, to register on Form N-4.
78
Specifically, one commenter stated that, in particular, registration on Form N-4 should be optional for “closed blocks,” or registered MVA annuity offerings that no longer involve the issuance of new contracts.
79
78
CAI Comment Letter; IRI Comment Letter.
79
CAI Comment Letter. This commenter urged that if such closed blocks were required to register on Form N-4, the compliance period be extended from 12 months to 24 months to provide the necessary time to convert an additional class of contract to the new registration form.
See infra
Section II.J. for a discussion of effective and compliance dates for all rules and forms associated with the final amendments.
After considering comments, we have determined to require insurance companies to register offerings of registered MVA annuities on Form N-4 to provide investors with the tailored information necessary to make an investment decision, as discussed above.
80
Further, given the parallels outlined above between RILAs and registered MVA annuities and the use of combination contracts that can offer RILAs, registered MVA annuities, and variable annuities, registering offerings of registered MVA annuities on Form N-4 will be efficient for investors, insurance companies, and the Commission. As a result, we are requiring, not just permitting, the use of Form N-4 for registered MVA annuities. Permitting insurance companies to register offerings of closed block registered MVA annuities on Forms S-1 or S-3 would not provide these investor benefits or efficiencies. It also would hamper comparability if different registered MVA annuities provided materially different disclosure. However, the Commission administers the requirements for prospectuses included in registration statements on Form N-4 in a way that allows variances in disclosure or presentation—including now those relating to closed blocks of registered MVA annuities—if appropriate for the circumstances involved while remaining consistent with the objectives of the form.
81
80
See supra
Sections I.B. and I.C.
81
See final Form N-4, General Instruction C.1.(d). This rulemaking does not affect the Commission position on existing variable contracts whose issuers provide alternative disclosures to investors as stated in the VASP Adopting Release at Section II.E.3.
As a result of this change, registered MVA annuities must make the disclosures required in Form N-4 to the extent applicable. For example, they must meet the requirements of the front and back cover pages to the extent the disclosures apply to the offering of registered MVA annuities being registered.
82
As outlined in the Proposing Release, we also are adopting a number of specific disclosure requirements for registered MVA annuities designed to accommodate their inclusion on the form and provide investors disclosures tailored to registered MVA annuity products and highlight key information about these products.
83
82
See, e.g., infra
Section II.C.1.
83
See
Proposing Release at Section II.H.
Table 1 outlines the key amendments, including certain conforming amendments, we are adopting to Form N-4 to accommodate offerings of registered MVA annuities:
Table 1—Overview of Form N-4 for Registered MVA Annuities
Item
Description
Substantive changes from the current form
Discussion
Prospectus (Part A)
N/A
Facing Page and General Instructions
Added registered MVA annuity contracts to list of permissible uses
Section II.C.8(a), Section II.C.8(b).
N/A
General Instructions
Added definition of “Contract Adjustment” to account for MVA fixed account options
Section II.C.8(b).
6
Description of the Insurance Company, Registered Separate Account, and Investment Options
New contract adjustment disclosures for MVA fixed account options
Section II.C.4(a).
7
Charges and Adjustments
New contract adjustment disclosures applicable to MVA fixed account options
Section II.C.6(b).
17
Investment Options Available Under the Contract
New contract adjustment disclosures for MVA fixed account options
Section II.C.4(b).
Statement of Additional Information (Part B)
26
Financial Statements
Providing that insurance companies can use the relevant instructions with regard to offerings of registered MVA annuities and adding requirements relating to changes in and disagreements with accountants for registered MVA annuities
Section II.E.
Other Information (Part C)
31A
Information about contracts with Index-Linked Options and Fixed Options Subject to a Contract Adjustment
New disclosure of registered MVA annuity specific information
Section II.C.7.
In addition to these changes to Form N-4, we are providing to registered MVA annuities the same offering and filing framework we are extending to RILAs for the same reason as we are making these changes for RILAs as discussed in more detail below.
84
This includes, for example, amendments permitting registered MVA annuities to use a summary prospectus, pay securities fees annually based on net sales, and use the same process to update their registration statements that will apply to RILAs. To implement the inclusion of registered MVA annuities in the amendments to the rules under the Securities Act, we also are adding a defined term “registered market value adjustment annuity” to rule 405 that is consistent with the amendments to Form N-4.
85
We are also extending the same requirements as to the use of Inline XBRL to registered MVA annuities for the same reasons we are extending these requirements to RILAs.
86
84
See infra
Sections II.C, D, E, and F.
85
“Registered market value adjustment annuity” is defined as an annuity or an option available under an annuity, that is not a registered index-linked annuity, and (1) that is deemed a security; (2) that is offered or sold in a registered offering; (3) that is issued by an insurance company that is subject to the supervision of either the insurance commissioner or bank commissioner of any State or any agency or officer performing like functions as such commissioner; (4) that is not issued by an investment company; and (5) whose contract value may reflect a positive or negative adjustment (based on calculations using a predetermined formula, a change in interest rates, or some other factor or benchmark) if amounts are withdrawn before the end of a specified period. This definition mirrors that of “registered index-linked annuity” we are adding to rule 405 for RILAs, other than the last provision which is based on the definition of “contract adjustment” we are adding to Form N-4.
86
See infra
Section II.C.10.
C. Contents of Form N-4
Consistent with the proposal, many items of current Form N-4 will apply to RILAs in final Form N-4. These existing items of current Form N-4 will also apply to registered MVA annuities. We are also adopting amendments to Form N-4 to require disclosures specific to RILAs as well as amendments that also will apply to offerings of variable annuities. Some of these disclosures will also apply to registered MVA annuities. Table 2 outlines the substantive amendments we are adopting to Form N-4.
87
87
Some of the final amendments entail a non-substantive change such as a change to a defined term or specifying that the provision would continue to be applicable only to a registered separate account or variable option. These are not discussed in the following table but are instead discussed in Sections II.C.8 and II.C.9
infra.
Table 2—Overview of Form N-4
Item
Description
Substantive changes from the current form
Discussion
Prospectus (Part A)
1
Front and Back Cover Pages
Adding new legends and other standardized disclosures
Section II.C.1.
2
Overview of the Contract
New non-variable annuity-specific disclosures; moving order of appearance up
Section II.C.2.
3
Key Information
New non-variable annuity-specific disclosures; changing to a question-and-answer format; moving order of appearance down; change discussion of restrictions on optional benefits to cover all benefits
Section II.C.3.
4
Fee Table
New contract adjustment disclosure
Section II.C.6(a).
5
Principal Risks of Investing in the Contract
Providing more detailed disclosures applicable to all issuers
Section II.C.5.
6
Description of the Insurance Company, Registered Separate Account, and Investment Options
New non-variable annuity-specific disclosures and one new item regarding variable options
Section II.C.4(a).
7
Charges and Adjustments
New disclosures related to contract adjustments; renamed item
Section II.C.6(b).
8
General Description of Contracts
No substantive change
Section II.C.9(b).
9
Annuity Period
No substantive change
Section II.C.9(b).
10
Benefits Available Under the Contract
No substantive change
Section II.C.9(b).
11
Purchases and Contract Value
No substantive change
Section II.C.9(b).
12
Surrenders and Withdrawals
No substantive change
Section II.C.9(b).
13
Loans
No substantive change
Section II.C.9(b).
14
Taxes
No substantive change
Section II.C.9(b).
15
Legal Proceedings
No substantive change
Section II.C.9(c).
16
Financial Statements
No substantive change (but see Item 26)
Section II.E.
17
Investment Options Available Under the Contract
New non-variable annuity-specific disclosures
Section II.C.4(b).
Statement of Additional Information (Part B)
18
Cover Page and Table of Contents
No substantive change
Section II.C.9(b).
19
General Information and History
No substantive change
Section II.C.9(c).
20
Non-Principal Risks of Investing in the Contract
No substantive change
Section II.C.9(b).
21
Services
No substantive change
Section II.C.9(b).
22
Purchase of Securities Being Offered
New disclosure of specific contract adjustment information
Section II.C.6(c).
23
Underwriters
No substantive change
Section II.C.8(c).
24
Calculation of Performance Data
Clarifying only applies to variable options
Section II.C.8.
25
Annuity Payments
No substantive change
Section II.C.9(b).
26
Financial Statements
Providing that insurance companies can use the relevant instructions relating to financial statements and adding requirements relating to changes in and disagreements with accountants for non-variable annuities
Section II.E.
Other Information (Part C)
27
Exhibits
Adding power of attorney for all issuers and accountant letters for non-variable annuity issuers as exhibits
Section II.C.8(d).
28
Directors and Officers of the Insurance Company
No substantive change
Section II.C.9(c).
29
Persons Controlled or Under Common Control with the Insurance Company or the Registrant
No substantive change
Section II.C.9(c).
30
Indemnification
No substantive change
Section II.C.9(c).
31
Principal Underwriters
No substantive change
Section II.C.9(c).
31A
Information about contracts with Index-Linked Options and Fixed Options Subject to a Contract Adjustment
New disclosure of non-variable annuity specific information
Section II.C.7.
32
Location of Accounts and Records
No substantive change
Section II.C.8.
33
Management Services
No substantive change
Section II.C.9(b).
34
Fee Representation and Undertakings
Adding new non-variable annuity undertakings
Section II.C.8(d).
1. Front and Back Cover Pages (Item 1)
Currently, issuers using Form N-4 are required to include on the front and back cover pages basic identifying information about the issuer and the contract, information on how to review the document (
e.g.,
what the SAI is and where to find it), as well as certain legends, for example, one relating to the ability for an investor to cancel the contract within 10 days.
88
We are adopting amendments to require insurance companies registering offerings of non-variable annuities to include this general information on the front and back cover pages of the prospectus, as well as non-variable annuity—specific disclosures on the front cover page. We are adopting these amendments substantially as proposed, with modifications in response to comments. The following table summarizes the cover page requirements, as amended:
88
See
current Form N-4, Item 1.
Table 3—Information Required by Item 1 of Form N-4 As Amended
Item No.
Disclosure
Cover
Changed from proposal?
Identifying Information
Item 1(a)(1)
Registered separate account's name
Front
No.
Item 1(a)(2)
Insurance company's name
Front
No.
Item 1(a)(3)
Types of contracts offered (
e.g.,
group, individual, etc.)
Front
No.
Item 1(a)(4)
Name and class of contract
Front
No.
Item 1(a)(5)
List of types of investment options offered under the contract with cross references to the appendix with further information about those options
Front
No.
Item 1(a)(9)
Date of prospectus
Front
No.
Item 1(b)(4)
EDGAR identifier number
Back
No.
Legends
Item 1(a)(6)
Statement that the contract is a complex investment and involves risks, including potential loss of principal
For contracts that include an index-linked option:
A prominent statement, as a percentage, of the maximum amount of loss that an investor could experience from negative index performance after taking into account the current limits on index loss, which may include a range of the maximum amount of loss if the contract offers different limits on index loss
Front
Yes. Revised statements about potential for investment loss, manner in which the insurance company determines the maximum loss due to negative index performance, and minimum limits on index gains and losses.
Prominent disclosure of any minimum limits on index losses that will always be available under the contract or, alternatively, a prominent statement that the insurance company does not guarantee that the contract will always offer index-linked options that limit index losses, which would mean risk of loss of the entire amount invested
A prominent statement that the insurance company limits the amount an investor can earn on an index-linked option. A prominent statement, for each type of limit offered (
e.g.,
cap, participation rate, etc.), of the lowest limit on index gains that may be established under the contract
Item 1(a)(7)
Statement that the contract is not a short-term investment and is not appropriate for an investor who needs ready access to cash. Statement that withdrawals could result in, among other things, surrender charges and negative contract adjustments, including a prominent disclosure stating, as a percentage, the maximum potential loss resulting from a negative contract adjustment, if applicable
Front
No.
Item 1(a)(8)
Statement that the insurance company's obligations under the contract are subject to its financial strength and claims-paying ability
Front
No.
Item 1(a)(10)
Statement that the Commission has not approved or disapproved of the securities or passed upon the accuracy or adequacy of the disclosure in the prospectus and that any contrary representation is a criminal offense (as required in 17 CFR 230.481(b)(1))
Front
No.
Item 1(a)(11)
Statement that additional information about the contract is available on
Investor.gov
Front
No.
Item 1(a)(12)
A legend that states that if you are a new investor, you may cancel your contract within 10 days of receiving it without paying fees or penalties with some details about the operation of this process including whether a contract adjustment will be applied to the returned amount
Front
No.
Other Information
Item 1(b)(1)
Statement that the SAI contains additional information, that it is available to investors, and how investors may obtain the SAI or make inquiries about their contracts
Back
No.
Item 1(b)(2)
Statement about whether and from where information is incorporated by reference
Back
No.
Item 1(b)(3)
Statement that reports and other information about the registered separate accounts and, if applicable, the insurance company, are available on the Commission's website and that copies of this information may be obtained
Back
Yes. Applied this requirement to insurance companies in addition to separate accounts.
We proposed to make several changes to the front cover page, including four additional disclosures in Item 1(a).
89
Certain proposed changes received no comments and we are adopting them as proposed:
89
See
Proposing Release at Section II.B.1.
(1) Changes to Item 1(a)(1) to require disclosure of “the registered separate account's name” whereas this item previously asked for “the registrant's name.”
(2) Changes to Item 1(a)(2) to require disclosure of “the insurance company's name” instead of the current requirement for “the depositor's name.”
(3) Changes to Item 1(a)(3) to require disclosure of the types of
contracts
offered by the prospectus (
e.g.,
group, individual, single premium immediate, flexible premium deferred), as opposed to the current form, which requires disclosure of the types of
variable annuity
contracts offered by the prospectus.
(4) New Item 1(a)(5), which requires disclosure of the types of investment options under the contract and a cross reference to the prospectus appendix providing additional information about each option.
(5) We also are moving certain items to different locations on the front cover page without changing the content of the required disclosure.
90
90
Specifically, on Form N-4, current Item 1(a)(5), which requires disclosure of the date of the prospectus, is moving to final Item 1(a)(9); current Item 1(a)(6), which requires a statement required by rule 481(b)(1) under the Securities Act, is moving to final Item 1(a)(10); current Item 1(a)(7), which requires a statement that additional information about certain investment products, including variable and non-variable annuities, has been prepared by Commission staff and is available at investor.gov, is moving to final Item 1(a)(11); and current Item 1(a)(8), which requires a legend stating that new investors to the contract may be able to cancel the contract within 10 days without paying fees or penalties, is moving to final Item 1(a)(12).
We are adding new Items 1(a)(6) and (7) to the front cover page of final Form N-4, which we are adopting with modifications from the proposal, as discussed below. The four items on the back cover page—Item 1(b)—are largely unchanged with the exception of extending the disclosure requirements (suggested by a commenter) of Item 1(b)(3) to include the insurance company, if applicable.
91
91
See
CAI Comment Letter. The modification to Item 1(b)(3) is discussed in further detail below. Current Item 1(b)(3) indicates that reports and information about the registered separate account are available on the Commission's website. That language has been retained in final Form N-4. The statement would address available reports about the insurance company only if applicable.
In addition, and as proposed, the additional disclosures on the front cover page also will be required for
registration statements relating to offerings of variable annuities filed on that form to the extent relevant.
92
Specifically, these are disclosures relating to the complexity of the investment and potential loss of principal, that the contract is not a short-term investment and the appropriateness of that investment, and that an insurance company's obligations under the contract are subject to its financial strength and claims paying abilities.
93
While these disclosures are important for investors in non-variable annuities, they also are relevant in many cases to investors in variable annuities.
92
See
Proposing Release at Section II.B.1. Commenters did not specifically address the inclusion of these disclosures for variable annuity offerings.
93
See
final Form N-4, Item 1(a)(6), (7), and (8).
The comments that we received on the proposed cover page requirements were mixed. One commenter generally supported these disclosures, stating that the proposal ensured that the most important disclosures about RILAs appear on the cover page.
94
Another commenter suggested that, other than the disclosures related to maximum loss, the proposed cover page disclosures were, for the most part, designed to result in short, concise, and sensible cover page disclosures.
95
Other commenters, however, raised concerns.
96
94
See
Better Markets Comment Letter.
95
See
CAI Comment Letter.
96
Commenters suggested that, should the Commission extend the use of Form N-4 to registered MVA annuities, their comments would also apply to disclosures related to those securities.
See, e.g.,
CAI Comment Letter (supporting some aspects of the proposal but criticizing the maximum loss disclosure on the cover page); VIP Working Group Comment Letter.
First, some commenters raised concerns about the volume of disclosures proposed to be included on the cover pages, particularly those related to the maximum losses.
97
One such commenter suggested that the inclusion of all of these disclosures could cut against the form's layered disclosure approach.
98
These cover page disclosures are generalized statements designed to put an investor on notice of key considerations to help an investor make informed decisions. In particular, they are designed to highlight the complexities and certain associated risks of non-variable annuities for investors, and including this key information on the cover page helps ensure that an investor has information about these key aspects of a non-variable annuity at the outset. The number of specific features and risks highlighted on the cover page is driven by the complex nature of the non-variable annuity being registered. Further, because these points are generalized on the cover page but discussed in more detail later in the prospectus, they are consistent with the concept of layered disclosure. These disclosures also should help investors better understand the nature of the various investment options available under the contract.
97
See
CAI Commenter Letter; VIP Working Group Comment Letter.
98
See
CAI Comment Letter.
Second, commenters addressed certain specific items the Commission proposed to include on the front cover page. Commenters raised particular concerns with the proposed requirement to disclose as a percentage the maximum amount of loss from negative index performance that an investor could experience after taking into account the minimum guaranteed limit on index loss provided under the contract.
99
Commenters objected to this disclosure because, in their view: (1) requiring RILA issuers to disclose this percentage was unnecessary because the chance of investors experiencing this maximum loss was extremely remote,
100
(2) the cover page lacks appropriate context for this percentage and instead RILA issuers should include a narrative (not numeric) disclosure stating that an investor could lose a significant amount of money by investing in an index-linked option,
101
and (3) such maximum potential loss disclosure was unwarranted because other issuers of securities are not required to include this information on the cover pages of their prospectuses.
102
Separately, some commenters similarly opposed the proposed requirement to disclose, as a percentage, the maximum potential loss resulting from a negative contract adjustment as such a maximum loss would also be unlikely.
103
99
Proposed Form N-4, Item 1(a)(6).
100
VIP Working Group Comment Letter (stating that the analysis done by OIAD in the OIAD Investor Testing Report suggested that losses on these products over the long term have historically been remote); Comment Letter of Benji Johnson (Oct. 31, 2023) (“Johnson Comment Letter”); CAI Comment Letter; Datop Comment Letter;
see also
ACLI Comment Letter.
101
CAI Comment Letter.
102
VIP Working Group Comment Letter; Johnson Comment Letter; Datop Comment Letter.
103
Proposed Form N-4, Item 1(a)(7).
See
CAI Comment Letter; VIP Working Group Comment Letter. Several commenters also suggested that these two maximum potential loss disclosures, one from index performance and the other from contract adjustments, could cause investors to mistakenly believe that such losses are likely. CAI Comment Letter; VIP Working Group Comment Letter; Johnson Comment Letter.
In response to comments opposing the proposed requirement to disclose as a percentage the maximum amount of loss from negative index performance or from a contract adjustment that an investor could experience, the final disclosure requirements are designed to reflect that the risk that an investor could lose a substantial amount of money due to negative index performance is a key risk of a RILA.
104
Similarly, loss related to negative contract adjustments is a key risk of all non-variable annuities. Providing the maximum possible loss in these circumstances on the front cover page will alert investors to these risks in concrete terms. Moreover, disclosure of a maximum “potential” loss is not intended to suggest the maximum loss is likely to occur. The form does not prevent the insurance company from providing additional appropriate context.
104
VIP Working Group Comment Letter; Johnson Comment Letter; CAI Comment Letter; Datop Comment Letter;
see also
ACLI Commenter Letter.
Although issuers of other securities like mutual funds and ETFs do not disclose the maximum potential loss associated with those securities, such products also are not generally structured to provide loss protection. For RILAs, in contrast, loss protection is a central feature of the product and an emphasis in RILA marketing.
105
Numeric disclosure of the potential maximum loss helps an investor understand the extent to which a given RILA provides loss protection in simple terms. This is particularly important because investor testing has shown that investors struggled with the mechanics of loss protection and the consequences of withdrawals.
106
Placing this disclosure on the front cover page is designed to put investors on notice that those loss protections can, in the context of RILAs, have limitations and highlight, in the context of all non-variable annuities, a potential consequence of withdrawals. A numeric example is well suited for the cover page because it communicates the extent of loss protection briefly and
concretely, and additional context will be available elsewhere in the prospectus.
105
One commenter raising concern with this disclosure's placement in the cover page “acknowledge[d] that the risk of loss associated with RILAs is an important concept to convey [and that] [u]nlike most other investments, RILAs provide a level of downside protection, and an investor should therefore understand the limits of that protection.” CAI Comment Letter.
106
OIAD Investor Testing Report at Section 5, Qualitative Testing, Results from Round 1.
See
Proposing Release at n.75 and accompanying text (investor testing participants struggled to understand loss limiting features, such as buffers), and at n.33 and accompanying text (investor testing participants often did not understand that there are multiple aspects of a typical RILA contract that could negatively affect an investor's contract value or the amount that the investor could withdraw from the contract (
e.g.,
surrender charges, interim value adjustments, and tax penalties)).
Commenters also raised concerns with various proposed disclosure requirements' reference to “minimum guaranteed” limits on index loss (or gain), including raising this concern with respect to the cover page.
107
Another commenter sought clarification regarding whether a similar disclosure requirement referring to guaranteed minimums for the life of the contract was intended to require insurance companies to establish such minimums.
108
107
See
VIP Working Group Comment Letter (stating that contracts do not include a minimum guaranteed limit on losses); CAI Comment Letter.
108
CAI Comment Letter.
See
Proposing Release at Section II.B.1. for a discussion of the proposed disclosure requirement.
We understand that not all RILAs provide minimum guaranteed limits on index loss for the life of the contract that could be used to calculate the proposed maximum possible loss due to negative index performance. After considering comments, we are modifying the language of this disclosure requirement to reflect this fact. Under the final amendments, the insurance company must prominently state as a percentage the maximum amount of loss from negative index performance that an investor could experience after taking into account the current limits on index loss provided by the index-linked options under the contract.
109
The insurance company may provide a range of the maximum amount of loss if the contract offers different limits on index loss. Basing this disclosure on the contract's actual current limits on index losses is designed to address commenters' concerns about RILAs without guaranteed limits, and permitting the insurance company to provide a range of losses allows the insurance company to reflect the range of loss protection offered under the contract.
109
We understand that, unlike the current limits on index
gain,
current limits on index
loss
do not change often, if at all, during the life of the contract.
See infra
Sections II.C.2 and II.C.3.a (discussing concerns raised by commenters relating to the disclosure of current limits on index gain).
We are modifying the proposed language of this disclosure requirement to specify that an insurance company that does not disclose a minimum limit on index loss that will always be available under the contract must prominently state that it does not guarantee that the contract will always offer index-linked options that limit index loss, which would mean risk of loss of the entire amount invested. We are requiring this disclosure because RILAs are long-term investments, with an investor's returns determined by the economic terms available both at the time of investment and during future crediting periods. The guaranteed minimum limits on index losses that always will be available—or the fact that the insurance company makes no guarantee at all—are key considerations for an investor considering a RILA that should be disclosed on the cover page. The final amendments' approach therefore incorporates the proposed requirement to disclose on the front cover page the maximum loss from negative index performance taking into account guaranteed minimum limits on index losses but, in response to comments, provides information on any guaranteed minimum limits without assuming that each RILA offers them.
110
110
These changes, which are contained in Item 1(a)(6)(a), are mirrored in Instruction 3(a) to Item 3 and Item 5(a).
See, e.g., infra
at footnote 386.
One commenter stated that it found confusing the proposed requirement to state that the potential for investment loss could be significantly greater than the potential for investment gain.
111
After considering comments we have determined not to require the proposed disclosure because an investor's potential inability to recoup prior losses due to limits on gains is a nuanced concept that is challenging to articulate in concise cover page disclosure. We are instead requiring the insurance company to disclose information about the contract's limits on participation in positive index performance, not only because these limits are central features of a RILA, but also because they can limit an investor's ability to recoup losses (which the proposed disclosure item was designed to convey). We therefore are requiring the insurance company to prominently state, for each type of limit offered (
e.g.,
cap, participation rate, etc.), the lowest limit on index gains that may be established under the contract.
112
This information is particularly important for an investor considering a RILA because RILAs are long-term investments and the investor's returns are driven not just by the economic terms available at the time of investment, but also in future crediting periods. In another change from the proposal, we are not adopting the proposed Item 1(a)(6) requirement to state that an investor could lose a significant amount of money if the index declines in value. We are doing so because the required disclosure in this item, and elsewhere on the form, of the maximum possible loss due to declines in index performance make clear that investors face the potential for losses in these circumstances.
113
111
See
Johnson Comment Letter;
see also
proposed Form N-4, Item 1(a)(6).
112
See
final Form N-4, Item 1(a)(6)(b).
113
See also, e.g.,
final Form N-4, Instruction 3(a) to Item 3.
Finally, one commenter suggested that we amend a current back cover page disclosure requirement regarding the availability of additional information to apply to RILAs.
114
This sub-item currently requires variable annuity prospectuses to state that reports and other information about a registered separate account may be found on the Commission's website.
115
The commenter suggested applying this requirement to insurance companies that issue RILAs to the extent that they provide reports and other information to the Commission through their regular reporting under the Exchange Act. We agree that some investors might find the information and reports about the insurance companies useful when making investment decisions and have adjusted this requirement in the final form accordingly.
116
114
CAI Comment Letter.
115
Current Form N-4, Item 1(b)(3).
116
See
final Form N-4, Item 1(b)(3). Because registered MVA annuities are also issued by an insurance company, not a registered separate account, this change will also apply to registration statements relating to offerings of those securities.
2. Overview of the Contract (Item 2)
We are, largely as proposed, amending the requirements for the Overview of the Contract (“Overview”) to include RILAs generally, require disclosure about certain key elements of any index-linked option offered under the contract, and highlight any contract adjustments. Consistent with the inclusion of registered MVA annuities on Form N-4, the Overview also will discuss these annuities, as applicable. As discussed below, this section will precede the KIT.
117
117
Because we are requiring the Overview to appear before the KIT, current Item 3 (Overview of the Contract) will be renumbered as Item 2.
See infra
Section II.C.3.
Under the final amendments, insurance companies that are registering non-variable annuities must provide the same Overview disclosures that are currently required for variable annuities, modified to include certain RILA-specific disclosures. All contracts registered on the form must provide an Overview with a concise description of the contract, including information about: (1) the contract's purpose; (2) the phases of the contract, including a discussion of the available investment options; (3) the primary features of the contract; and (4) contract
adjustments.
118
We are adopting these amendments as proposed. Because offerings of registered MVA annuities will be registered on Form N-4, these requirements also will apply to offerings of registered MVA annuities, as applicable. No substantive changes from the proposed approach, however, were necessary to address registered MVA annuities.
118
Final Form N-4, Item 2(a)-(d).
In addition to information about the purpose of the contract, under the final amendments, a prospectus that offers index-linked options must include in the Overview (as part of the discussion of the phases of the contract): (1) a statement that the insurance company will credit positive or negative interest at the end of a crediting period to amounts allocated to an index-linked option based, in part, on the performance of the index; (2) a statement that an investor could lose a significant amount of money if the index declines in value; (3) an explanation that the insurance company limits the negative or positive index returns used in calculating interest credited to an index-linked option at the end of its crediting period, accompanied by a brief description and an example of the manner in which such returns may be limited; and (4) disclosure of guaranteed minimum limits on index losses or gains.
119
We are adopting the amendments described in (1)-(3) generally as proposed. We are adopting changes to the language of the proposed disclosure requirements addressing minimum limits on index losses and gains, which will be parallel to changes we are adopting to this language throughout Form N-4, as discussed in more detail below.
120
Specifically, we are changing the language of the proposed disclosure requirement addressing minimum limits on index losses to specify that an insurer that does not offer a minimum guaranteed limit on index losses must disclose that fact. We are adopting changes to the proposed language of the requirement for disclosing minimum limits on index gains to specify that insurers must prominently state, for each type of limit offered (
e.g.,
cap, participation rate, etc.), the lowest limit on index gains that may be established under the contract.
121
119
Final Form N-4, Items 2(b)(2)(i)-(iv).
120
Final Form N-4, Item 2(b)(2)(iii).
121
Final Form N-4, Items 2(b)(2)(iii) and (iv).
As proposed, the Overview also will provide, if applicable, a discussion of contract adjustments that must include a statement that an investor could lose a significant amount of money due to the contract adjustment if amounts are removed from an investment option or from the contract prior to the end of a specified period, accompanied by a brief description of the transactions subject to a contract adjustment.
122
In a change from the proposal, we are not adopting the proposed requirement to include in the Overview numeric risk of loss disclosures associated with negative index performance or contract adjustments, as discussed further below.
122
Final Form N-4, Item 2(d). Although one commenter suggested that we relocate the proposed disclosure item for contract adjustments under the sub-item for index-linked option disclosures, we are not making this change because contract adjustments are not specific to index-linked options; they apply to MVA annuity options as well. In a change from the proposal, we are replacing “index-linked option” with “investment option” to convey contract adjustments are associated with other types of investment options in addition to index-linked options.
As proposed, the Overview will precede the KIT. We are reordering these sections based on investor testing results indicating that investors reviewing sample KIT disclosure had difficulty understanding the basic features and concepts of RILA contracts, for example, “index,” “investment term,” “interim value adjustment,” and “buffer.”
123
The Overview provides general information about the contract and important context about the information summarized in the KIT. In particular, the Overview will, as discussed below, require descriptions and examples to help investors understand these RILA features, including contract adjustments, which we anticipate will provide a basis for better understanding the issues that the KIT disclosures address. Based on our observations of investor testing, investors may generally benefit from having more context in order to understand the KIT disclosures. Placing the Overview first may similarly provide context for the issues flagged in variable annuity KITs.
123
See, e.g.,
OIAD Investor Testing Report at Section 5, Qualitative Testing, Results from Round 1, Summary of Qualitative Testing, Section 6, Quantitative Testing, Summary of Quantitative Testing.
We received one comment on this proposed reordering in Form N-4. The commenter stated that the repetition of certain information in both the Overview and the KIT undermines our rationale for proposing to reorder the two sections.
124
We disagree that covering some of the same topics in the Overview and the KIT is inconsistent with changing the order of these disclosures. The KIT is designed to identify, in a consolidated location, key risks and features of the contract it describes.
125
Certain of this information is also included in the high-level contract summary provided in the Overview. The disclosure is included in both locations to allow the reader to understand the contract at a high level (in the Overview of the Contract), as well as key features and risks of the annuity whose offering is being registered (in the KIT). Further, KIT requirements that address the same topic in different contexts may aid investor understanding of complex disclosure, and this approach is consistent with a layered disclosure approach.
124
See
CAI Comment Letter.
125
See
VASP Adopting Release at paragraph following n.106.
In terms of the proposed content requirements for the Overview section, one commenter generally supported the proposed amendments.
126
This commenter not only stated that the proposed amendments to the Overview were generally appropriate (including requirements applicable to RILAs and variable annuities), but also that the proposed disclosure requirements regarding the index-linked options “cover most of the key aspects that investors should be aware of to understand the cyclical nature of the index-linked options,” and “strike the right balance by providing investors with the proper level of summary disclosure, with additional information appearing later in the prospectus.” While no commenter generally opposed our proposed changes, several requested modifications to some of the specific proposed disclosures.
126
CAI Comment Letter.
As discussed above, some commenters raised general concerns about disclosure that appears in both the Overview and the KIT and suggested that we reduce or eliminate perceived duplicative disclosure in those two sections to simplify and streamline the prospectus.
127
Such comments largely concerned the proposed narrative and numeric risk of loss disclosures for index-linked options and contract adjustments. One commenter stated it did not oppose the inclusion of narrative and numeric risk of loss disclosure in the Overview for end-of-term index declines and negative contract adjustments because “the generally free-writing nature of the Overview allows the registrant to provide appropriate context for the reader.”
128
Conversely, two commenters generally opposed the proposed risk of loss disclosures for negative index performance and
contract adjustments on the grounds that RILA issuers should not be required to make disclosures that are not required of variable annuities, and cited concerns that such disclosures incorrectly portray such products as high-risk investments.
129
127
CAI Comment Letter; ACLI Comment Letter.
128
CAI Comment Letter.
129
ACLI Comment Letter; Gainbridge Comment Letter.
One of these commenters stated that the proposal to require RILA issuers to disclose that an investor could lose a “significant amount of money” is inconsistent with existing disclosure for variable annuity products, which requires a statement that “an investor can lose money by investing in the Contract.”
130
This commenter stated that a RILA investor is at no greater risk of losing a more substantial amount of money than a variable annuity investor, and that if all performance variables were equal, a RILA investor has reduced risk of loss compared to a variable annuity investor because RILAs have the added benefit of downside protection. This commenter also objected to the proposed requirement to disclose in the Overview that an investor could lose a “significant” amount of money due to an index decline or a contract adjustment, viewing that term as subjective. Another commenter asked that we modify the proposed narrative risk of loss disclosure for negative contract adjustments to state that losses could be significant under “extreme market conditions.”
131
This commenter also opposed requiring numeric risk of loss disclosure associated with a negative contract adjustment on the grounds that the narrative disclosure “is sufficient without including a numeric figure.” One commenter asked that we clarify that the proposed numeric risk of loss disclosure for contract adjustments could be modified to avoid any implication that the risk of loss is greater than 100%.
132
130
ACLI Comment Letter.
131
VIP Working Group Comment Letter.
132
CAI Comment Letter.
We are adopting the Overview's narrative risk of loss disclosures largely as proposed.
133
These disclosures, each of which is a single sentence, are appropriate in light of the fact that RILAs, unlike variable annuities and other investment companies, are structured products that have unique features and risks despite contract similarities to variable annuities. Unlike variable annuities, index-linked options offer downside protection from market declines—and are marketed on that basis. The disclosures we are adopting will alert RILA investors that there are limits to those protections. Moreover, we are retaining the proposed requirement to state that an investor could lose money, with the “significant” descriptor designed to put investors on notice of losses they might not anticipate, given that investor testing revealed that investors tend to overestimate loss protection.
134
Significant losses associated with index-linked options may be infrequent, but they can and do happen, and investors should be aware of the possibility. We also are not modifying the proposed disclosure requirement to state that significant losses associated with contract adjustments may only occur under “extreme market conditions” because an investor who withdraws from a contract before the end of the crediting period may suffer significant losses relative to the value of the initial investment, regardless of market conditions. Nevertheless, the form does not prohibit an insurer from accompanying the required statement with contextual disclosure that explains when significant losses associated with contract adjustments might occur.
133
Final Form N-4, Items 2(b)(2)(ii) and 2(d). The only change we are adopting to the narrative risk of loss disclosure requirements is a revision to Item 2(d), replacing “Index-Linked Option” with “Investment Option,” to clarify that contract adjustments may apply to options other than index-linked options.
134
See
OIAD Investor Testing Report at Section 5, Qualitative Testing (qualitative interviews suggested confusion with RILA terms and concepts relating to, for example, loss limiting features such as buffers).
While we are adopting the narrative risk of loss disclosures as proposed, in a change from the proposal and in response to comments raising concerns about duplicative disclosure, we are not adopting the proposed numeric risk of loss disclosures associated with index declines or contract adjustments in the Overview. This change recognizes that the proposed numeric disclosures appear on the cover page, as well as the KIT, and, as one commenter observed, the Overview and the KIT are designed to be read together.
135
Requiring narrative-only risk of loss disclosure in the Overview is sufficient to flag this potential risk for investors because it will be immediately followed by the KIT, which will require the numeric risk of loss disclosure.
136
Although one commenter suggested we require numeric disclosure in the Overview rather than the KIT, as discussed further below, the brevity of the numeric disclosure is well suited to the KIT.
137
135
CAI Comment Letter.
136
Final Form N-4, Instructions 2(a) and 3(a) to Item 3.
137
CAI Comment Letter.
See also infra
footnote 174 and accompanying paragraph for related discussion.
Some commenters sought clarification regarding whether our proposal to require insurers to disclose guaranteed minimum limits on index losses or gains effectively seeks to impose a substantive requirement for insurance companies to offer minimum limits.
138
One commenter asked whether a prospectus for a contract that does not offer minimum limits may omit the proposed disclosure.
139
The proposal—and the final amendments we are adopting—are designed to result in clear disclosure of minimum limits that are an inherent feature of the contract, not to dictate contract terms or prescribe specific minimum limits.
138
CAI Comment Letter; VIP Working Group Comment Letter; Gainbridge Comment Letter.
139
VIP Working Group Comment Letter; Gainbridge Comment Letter.
For downside protection, we understand some RILA issuers may not offer index-linked options with minimum limits on index losses that will always be available under the contract. Because downside protection is one of the chief selling points for index-linked options, a particular RILA not offering minimums on index losses that will always be available under the contract is material information that must be prominently disclosed in the prospectus. Without downside protection, investors are at risk of losing their entire investment due to poor index performance. And without a minimum rate of downside protection that will always be available under the contract, an investor is considering making a long-term investment without certainty as to the amount of downside protection that will apply to future crediting periods. Likewise, without disclosing a minimum limit on index gains that will always be available under the contract, an investor would not know the extent to which investments in future index-linked options would result in credited interest when there is positive index return. To help ensure that investors have this information while also responding to comments requesting clarification, we are modifying the proposed requirement to disclose guaranteed minimums on index losses. Instead, the final amendments require the insurer to prominently disclose any minimum limits on index losses that will always be available under the contract, or, alternatively, prominently state that the insurer does not guarantee that the contract will always offer index-linked
options that limit index losses.
140
In addition, largely as proposed, we are adopting a requirement for insurers to disclose the minimum limits on index gains guaranteed for the life of the contract, with some changes to the proposed language to address commenters' requests for clarification.
141
140
Final Form N-4, Item 2(b)(2)(iii).
141
Proposed Form N-4, Item 2(b)(2)(iv) would have required insurers to “[d]isclose the minimum limit on Index gains guaranteed for the life of the Contract for any Index-Linked Option,” whereas final Form N-4, Item 2(b)(2)(iv) will require insurers to “[p]rominently state, for each type of limit offered (
e.g.,
cap, participation rate, etc.), the lowest limit on Index gains that may be established under the Contract.”
These changes from the proposal are intended to clarify that this requirement is designed to seek disclosure on the minimum limit on index gains that will always be available under the contract for each type of limit offered. The final amendments also conform this disclosure requirement with our understanding of current practices and the nature of RILA investments—that is, while an insurance company may not offer loss protection, a RILA inherently involves some degree of participation in index gains. The insurance company therefore must disclose the minimum extent to which investors can participate in index gains under the contract. Specifically, the final rule will require the insurer to prominently state, for each type of upside limit being offered (
e.g.,
cap, participation rate, etc.), the lowest limit on index gains that may be established under the contract.
142
142
Final Form N-4, Item 2(B)(2)(iv). We are requiring parallel disclosure in other Items of final Form N-4 relating to disclosure of minimum limits on index losses and/or gains that will always be available under the contract.
See also
final Form N-4, Item 1(a)(6); Item 5(a); Item 6(d)(2)(i)(B); and Item 17(b).
3. Key Information Table (Item 3)
The KIT requirements in Form N-4 currently require a brief description of key facts about a variable annuity to appear in the prospectus, in a specific sequence and in a standardized presentation.
143
The KIT functions as an integral part of the layered disclosure in Form N-4 by identifying key considerations upfront, with more detail to follow later in the prospectus. We are adopting the final amendments generally as proposed with modifications to address comments we received. As proposed, we are requiring that insurance companies provide a KIT in registration statements relating to RILA offerings, as is currently done with variable annuities, and in a modification from the proposal are extending this requirement to offerings of registered MVA annuities.
144
We are adopting amendments to the current KIT requirements to highlight key features of non-variable annuities, with some modifications from the proposal in response to comments. These amendments are informed by investor testing and are designed to build on the existing KIT disclosure framework and highlight important considerations related to non-variable annuities, including certain aspects of RILAs that our investor testing observed are difficult for investors to understand and thus require clear disclosure in order to help investors make informed investment decisions.
145
In addition, as proposed, we are adopting amendments to the KIT that will apply to both non-variable and variable annuities that are designed to provide investors with a better understanding of these products.
143
For variable annuity issuers who rely on rule 498A to provide summary prospectuses to investors, the KIT currently appears as a disclosure item in the summary prospectus.
144
See
final Form N-4, General Instruction B.1 and Instruction 1(a)-1(c) to Item 3.
145
See, e.g.,
OIAD Investor Testing Report at Section 5, Qualitative Testing (following two rounds of in-depth interviews to assess potential RILA KIT disclosure for areas of confusion or misunderstanding, qualitative interviews suggested confusion with RILA terms and concepts relating to, for example, contract adjustments such as interim value adjustments and loss limiting features such as buffers); OIAD Investor Testing Report at Section 6, Quantitative Testing, Results, Subgroup Analysis (noting 5.7 percentage point effect of the Q&A KIT structure on overall comprehension for “non-investors” during quantitative testing).
Commenters generally supported the proposed requirement that insurance companies provide a KIT in RILA registration statements.
146
Comments on the proposed amendments affecting the KIT's specific format and disclosure requirements, however, were mixed.
147
One commenter supported the proposed amendments to the KIT.
148
This commenter stated that the disclosure required to appear in the KIT provides investors with a complete picture of RILA risks in a prominent place. In contrast, other commenters supported a portion of the proposed amendments to the KIT but also opposed certain of the proposed amendments, as discussed further below.
149
Commenters suggested that, should the Commission extend the use of Form N-4 to registered MVA annuities, their comments would also apply to disclosures related to those securities, to the extent applicable.
150
146
See, e.g.,
Gainbridge Comment Letter (stating that the KIT requirement for RILA issuers will allow investors to readily compare RILAs to each other and to variable annuities); Better Markets Comment Letter (stating that a RILA-tailored KIT is key to helping investors understand the RILA-specific risks presented to them).
147
See, e.g.,
Better Markets Comment Letter; CAI Comment Letter.
148
See
Better Markets Comment Letter.
149
See
CAI Comment Letter (stating that the SEC has generally struck the correct balance in the KIT, with some exceptions); ACLI Comment Letter (stating that it supports CAI's comments and opposing the KIT amendments requiring a Q&A format and repetition of Overview disclosure).
150
See, e.g.,
CAI Comment Letter.
The overall format of the final KIT is depicted below:
Table 4—Key Information Table as Adopted
Fees, Expenses, and Adjustments:
Are There Charges or Adjustments for Early Withdrawals?
Are There Transaction Charges?
Are There Ongoing Fees and Expenses?
Risks:
Is There a Risk of Loss from Poor Performance?
Is this a Short-Term Investment?
What Are the Risks Associated with the Investment Options?
What are the Risks Related to the Insurance Company?
Restrictions:
Are There Restrictions on the Investment Options?
Are There any Restrictions on Contract Benefits?
Taxes:
What Are the Contract's Tax Implications?
Conflicts of Interest:
How Are Investment Professionals Compensated?
Should I Exchange My Contract?
a. Formatting of the KIT
Form N-4 currently prescribes format requirements for the KIT to enhance the readability and comparability of the disclosure.
151
As proposed, we are adopting amendments to Form N-4 to require these current format requirements to apply to all offerings registered on Form N-4, including non-variable annuity offerings.
152
Specifically, the final amendments will require insurance companies to disclose required KIT information in the tabular presentation reflected in the instructions, in the order specified, without any modification or substitution with alternate terminology of the title, headings, and sub-headings for the tabular presentation, unless the instructions otherwise provide. Insurance companies will be permitted to exclude any disclosures (other than the title, headings, and sub-headings for this tabular presentation) in the KIT that are not applicable or modify any of the statements required to be included, so long as the modified statement contains comparable information. Insurance companies also will be required to provide cross-references to the location in the statutory prospectus where the subject matter is described in greater detail, and in the case of electronic versions of the prospectus, to make those references accessible either by direct electronic link or through equivalent methods or technologies, as required for variable annuity KIT disclosure. Insurance companies will include these cross-references adjacent to the relevant disclosure, either within the table row, or presented in an additional table column. All disclosures in the KIT should be short and succinct, consistent with the limitations of a tabular presentation.
151
See
current Form N-4, Instruction 1 to Item 2.
152
See
final Form N-4, Instruction 1(a)-(c) to Item 3.
Commenters generally supported the application of the current KIT format requirements to RILA offerings.
153
In response to one of the Proposing Release's requests for comment, one commenter stated that the KIT should continue to permit insurance companies to cross-reference relevant sections of the prospectus either within the applicable row of the KIT or as an additional column rather than requiring issuers to add a new column in the KIT labeled “Location in the Prospectus.”
154
We agree and are maintaining the current requirements for cross-reference location because staff, investors, and RILA issuers are familiar with these requirements, and investor testing did not identify any concerns with this aspect of the KIT.
155
153
See
Better Markets Comment Letter (expressing that the proposed KIT requirements present RILA risks in a format that investors will easily understand); CAI Comment Letter (stating that the proposed KIT presentation is similar to the presentation currently used by insurance companies for combination RILA/variable annuity offerings and that this presentation will work equally well for combination and standalone RILAs registered on Form N-4).
154
See
CAI Comment Letter.
155
See generally
Proposing Release at Section 1.C.
We are adopting, as proposed, three amendments to the KIT formatting and presentation requirements in Form N-4 that will apply to registration statements both for non-variable and variable annuities. These changes are designed to provide investors with a better understanding of these products and are informed in part by the results of investor testing. First, we are adopting, generally as proposed, a requirement that issuers present information in the KIT in a question-and-answer (“Q&A”) format.
156
As a result of this change, the various line items of the KIT will be rephrased as questions (
e.g.,
“Are There Charges or Adjustments for Early Withdrawals?” instead of “Charges for Early Withdrawals or Adjustments”). The instructions will further require that, unless the context otherwise requires, issuers must begin the response with a “Yes” or “No” in bold text when answering a question presented in a given row of the KIT.
156
See
final Form N-4, Instruction 1(d) to Item 3.
Comments on the Q&A format were mixed.
157
One commenter expressed that the Q&A format may be helpful and more accessible to some investors but may also result in a less concise and simple KIT.
158
Another commenter opposed the Q&A format on the grounds that it would result in more narrative responses, which would make comparisons between products more difficult for investors.
159
This commenter favored retaining the current wording.
157
See
ACLI Comment Letter; CAI Comment Letter.
158
See
CAI Comment Letter.
159
See
ACLI Comment Letter.
After considering comments received, we are adopting the Q&A format generally as proposed, except for the Charges or Adjustments for Early Withdrawals and the Risks Related to the Insurance Company line items, each of which we discuss in further detail below. Rephrasing the current line items in a Q&A format should more effectively convey the KIT information to investors and will therefore help non-variable and variable annuity investors make informed investment decisions. As stated in the Proposing Release, the Q&A format should improve investor comprehension of non-variable annuity-specific topics based on the results of our quantitative investor testing.
160
Because our investor testing showed that the Q&A format impacted overall comprehension more for non-investors than independent investors, the Q&A format should particularly improve comprehension for less-experienced investors.
161
Because the KIT disclosures as amended continue to be brief by their nature, we anticipate that any negative impact the Q&A format
may have on comparability or conciseness will be justified by the benefit that investors will gain from understanding complex non-variable annuity-specific information.
160
See
Proposing Release at Section II.B.2.
161
See
Proposing Release at n.78 and accompanying text. For purposes of investor testing, participants were classified into three groups: those with no investments in stocks, bonds, mutual funds, or other securities (non-investors); those with investments exclusively in retirement savings accounts (retirement only); and those with investments outside of retirement accounts (independent investors).
See
OIAD Investor Testing Report at Section 6, Quantitative Testing, Subgroup Analysis, Investor Status.
Second, we are adopting, as proposed, amendments changing the order in which the KIT (Item 2 of current Form N-4) appears relative to the Overview of the Contract (Item 3 of current Form N-4), as discussed above.
162
162
See supra
Section II.C.2. The current instructions to Form N-4 require that, notwithstanding 17 CFR 230.421(a), the KIT, Overview of the Contract, and Fee Table must be disclosed in the numerical order in which they appear in Form N-4. The final form changes this instruction to reflect the change in order.
See
final Form N-4, General Instruction C.3(a). The change in order will also apply to summary prospectus disclosure location under the final amendments to rule 498A.
Third, as proposed, we are deleting Form N-4's general instruction stating that where the discussion of information required by the Overview of the Contract or KIT also responds to the disclosure requirements in other items of the prospectus, registrants need not include additional disclosure in the prospectus that repeats the information disclosed in the Overview of the Contract or the KIT.
163
Comments on the deletion were mixed.
164
One commenter stated that there is value in “strategically locating certain disclosures in multiple places to help investors.”
165
Another commenter opposed this deletion because it would lead to certain information appearing more than once in the prospectus.
166
163
See
final Form N-4, General Instruction C.3(a).
164
See
ACLI Comment Letter; CAI Comment Letter.
165
See
CAI Comment Letter.
166
See
ACLI Comment Letter.
In administering Form N-4, we have observed that this instruction has led to confusion on the part of registrants. Moreover, as discussed above, the layered disclosure framework requires certain disclosure topics to be discussed in multiple locations.
167
This framework is designed to help ensure both that the KIT contains key disclosures and that the more-detailed sections to which investors are directed contain all of the key information about the given topic.
168
This approach is particularly important for RILAs in light of the challenges our investor testing showed investors have in understanding these products, in that investors will see key disclosures in one place—the KIT—regardless of whether they review targeted sections of the prospectus.
167
See supra
Section I.D.2.
168
For example, while both the KIT and Item 5 require disclosures about principal risks, the KIT currently expressly contemplates that more detailed information will be repeated later in the prospectus, specifically requiring registrants to provide cross-references to the more detailed prospectus discussion.
See
current Form N-4, Instruction 1(b) to Item 2. This instruction remains unchanged in the KIT of the final Form N-4.
See
final Form N-4, Instruction 1(b) to Item 3. Item 5 requires registrants to summarize the principal risks of the contract in one place, and was not intended to permit an insurance company to omit principal risks from that section if those risks were also disclosed in the KIT.
See
Proposing Release at n.86 and accompanying text (“The principal risks section is designed to provide a consolidated presentation of principal risks which can be cross-referenced by registrants to reduce repetition that might otherwise occur if the same principal risks are repeated in different sections of the prospectus.”).
b. Fees, Expenses, and Adjustments
Non-variable annuities typically have implicit fees, expenses, charges, and adjustments for early or mid-term withdrawals that can be confusing or surprising to investors. This was observed in our investor testing regarding RILAs.
169
We anticipate that investors will benefit from tailored disclosure about certain unique features of a non-variable annuity's fee and expense structure as described below to help them make informed decisions.
169
See supra
Section I.D.1.
Early Withdrawal Charges and Adjustments.
The first line item in the “Fees, Expenses, and Adjustments” section of the amended KIT, “Are There Charges or Adjustments for Early Withdrawals?,” addresses surrender charges and contract adjustments. Because non-variable annuities may have surrender charges, we are adopting, as proposed, a requirement that insurance companies provide the existing KIT surrender charge disclosure in this first line item so that investors understand how surrender charges are assessed (
e.g.,
that if they make a withdrawal within a specified period after their last premium payment, they may pay a significant surrender charge that will reduce the value of their investment).
170
This disclosure must include the maximum surrender charge, the maximum number of years that a surrender charge may be assessed, and an example of the maximum surrender charge an investor could pay in dollars based on a $100,000 investment. In a change to the current form requirements, we also are requiring, as proposed, that insurance companies disclose that this loss will be greater if there is a negative contract adjustment, taxes, or tax penalties, to make clear that an investor may lose more than just the surrender charge upon an early withdrawal.
170
Final Form N-4, Instruction 2(a) to Item 3.
We also are requiring specific disclosure on contract adjustments, which can result in investor losses if the investor withdraws money from an investment option, or withdraws money from the non-variable annuity entirely, before the end of a specified period.
171
We are adopting these requirements as proposed except that they will apply to contract adjustments applicable to registered MVA annuities as well as RILAs. Specifically, if the contract includes contract adjustments, the insurance company will be required to include a statement that if all or a portion of contract value is removed from an investment option or from the contract before the expiration of a specified period, the insurance company will apply a contract adjustment, which may be negative. This statement will include the maximum potential loss (as a percentage of the investment) resulting from a negative adjustment. The insurance company also will be required to provide an example of the maximum negative adjustment that could be applied (in dollars) assuming a $100,000 investment. We are also adopting, as proposed, a requirement that the insurance company provide a brief narrative description of the contract transactions subject to a contract adjustment (
e.g.,
withdrawals, surrender, annuitization, etc.) as part of the response to this item to make clear to investors the range of transactions that could result in a contract adjustment.
171
Contract adjustments include adjustments made when amounts are removed prematurely from an index-linked option, often referred to as interim value adjustments, as well as adjustments made when amounts are removed prematurely from the contract, often referred to as market value adjustments. Thus, a specified period would include index-linked option crediting periods (which again, are typically referred to by insurance companies as “investment terms” or “terms”), as well as any specified period relating to a market value adjustment.
Commenters generally opposed one or more of the amendments to the early withdrawal charges line. One commenter specifically opposed the inclusion in the KIT of numeric maximum potential loss disclosure (as a percentage of an investment) due to a negative contract adjustment on the grounds that the KIT's design would not provide adequate context for the disclosure and could therefore lead investors to believe that such losses are likely, even when the risk of loss is remote.
172
This commenter suggested instead that the KIT should contain only narrative statements regarding the risk of loss. The commenter also opposed the inclusion in the KIT of this numeric loss disclosure because it is included in other parts of the prospectus. While we
are adopting changes to this proposed disclosure elsewhere in the prospectus, we are adopting amendments to this first line item of the KIT as proposed.
173
While we appreciate that this disclosure appears elsewhere in the prospectus, including the numeric maximum potential loss disclosure in the KIT in particular is appropriate because the brevity of numeric disclosure and its effectiveness in communicating this key risk of loss is well suited for the KIT. In this regard, the KIT was designed to “provide a brief description of key facts” and be “easy to read and navigate.”
174
Further, additional context for the numeric disclosure will be provided by cross-references to other parts of the prospectus.
175
As discussed above,
176
the inclusion of numeric loss disclosure in both the KIT and elsewhere in the prospectus is consistent with a layered disclosure approach and is designed to help investors make more informed investment decisions. Also, as discussed above, the form does not prevent the insurance company from providing additional appropriate context.
177
172
See
CAI Comment Letter.
173
See supra
Section II.C.2.
174
See
VASP Adopting Release at paragraph following n.106.
175
See
final Form N-4, Instruction 1(b) to Item 3.
176
See supra
Sections III.A.2, II.C.1, and II.C.2 (discussing numeric loss disclosure in the context of the prospectus's layered disclosure approach, cover page, and Overview, respectively).
177
See supra
Sections II.C.1, and II.C.2.
One commenter suggested that the example of the maximum negative adjustment that could be applied (in dollars) assuming a $100,000 investment should not be required if the maximum potential loss (as a percentage of an investment) due to a negative adjustment is retained.
178
This commenter expressed that, where the percentage maximum potential loss is 100% under a RILA, a typical investor would understand the dollar amount associated with that loss and would not need the example. We are retaining this example because it illustrates how an investment can be impacted by a negative contract adjustment in dollar figures, which may be more salient to some investors than a percentage.
178
See
CAI Comment Letter. The instructions to this line item provide an example of this disclosure that includes the statement that the loss “will be greater if you also have to pay a surrender charge, taxes, and penalties.” One commenter recommended that, if the Commission does require an example of maximum negative adjustments, the Commission should ensure that the form instructions do not require insurance companies to state or imply that the loss could be greater than 100% due to other factors, such as surrender charges.
See
CAI Comment Letter. The language in the form relating to greater losses due to these other factors is an example provided in a specific context, and insurance companies will not be required to make this disclosure where it is not correct.
One commenter stated that requiring disclosure relating to interim value adjustments under the “Fees and Expenses” heading is inappropriate because interim value adjustments are not fees but are instead the approximate fair market value of the investments underpinning the RILA.
179
We are retaining negative contract adjustment disclosure under the heading of the KIT that addresses fees and expenses. Interim value adjustments operate like an implicit fee in that they have a similar impact on an investor as an explicit fee or expense by decreasing the amount of an investor's investment. Further, including information about interim value adjustments under this heading may aid investors' understanding of their potential effects since investor testing showed that investors struggled to understand the concept of interim value adjustments in general.
180
To address the commenter's concern that the disclosure could imply that a contract adjustment is a conventional fee or expense, we have renamed this section of the KIT “Fees, Expenses,
and Adjustments
” and changed the question in the left-hand column of the early withdrawal charges and adjustments line item to read “Are There Charges
or Adjustments
for Early Withdrawals?” (italics indicating text in final Form N-4 that has been added to the proposed text).
181
179
See
VIP Working Group Comment Letter.
180
See
OIAD Investor Testing Report at Section 5, Qualitative Testing.
181
See also infra
Section II.C.6.a (regarding similar changes relating to the transaction expense table).
Transaction Charges.
The second line item in the “Fees, Expenses, and Adjustments” section of the amended KIT, “Are There Transaction Charges?,” will require registrants to disclose that the investor may also be charged for other transactions in addition to surrender charges (and now contract adjustments), along with a brief narrative description of the types of such charges (
e.g.,
front-end loads, charges for transferring cash value between investment options, etc.).
182
This line item is designed to provide a simple narrative description to alert investors that surrender charges and contract adjustments are not the only charges they could pay when they engage in certain contract transactions. We did not receive comments on this line item, and we are adopting these requirements as proposed.
182
Final Form N-4, Instruction 2(b) to Item 3.
Ongoing Fees and Expenses.
The third line item in the “Fees, Expenses, and Adjustments” section, “Are There Ongoing Fees and Expenses?,” is designed to alert investors that they will bear recurring fees on an annual basis. This item currently requires the insurance company to disclose (1) a minimum and maximum annual fee table and (2) a lowest and highest annual cost table, both along with applicable legends.
183
We are adopting amendments requiring insurance companies to provide this disclosure with respect to RILAs, as proposed, and registered MVA annuities, in a change from the proposal.
184
183
See
current Form N-4, Instruction 2(c) to Item 2. The minimum and maximum annual fee table requires a tabular description of the fees and expenses that an investor may pay each year, depending on the investment options chosen. This includes minimum and maximum percentages for: base contract fees; portfolio company fees and expenses; and optional benefits available for an additional charge. The lowest and highest annual cost table requires a tabular description of the lowest and highest cost an investor could pay each year, based on current charges and a set of standardized assumptions (
e.g.,
$100,000 investment and 5% annual appreciation).
184
See
final Form N-4, Instruction 2(c) to Item 3.
We also are adopting, largely as proposed, amendments requiring that, where a contract imposes limits on gains on the amount an investor can earn on an index-linked option, insurance companies must disclose that they impose these limits on gains and that they can act as an implicit ongoing fee.
185
185
See
final Form N-4, Instruction 2(c)(i)(G) to Item 3.
Specifically, insurance companies must disclose that: (1) there is an implicit ongoing fee on index-linked options to the extent that an investor's participation in index gains is limited by the insurance company through the use of a cap, participation rate, or some other rate or measure; (2) this means that the investor's returns may be lower than the index's returns; (3) in return for accepting this limit on index gains, an investor will receive some protection from index losses; and (4) this implicit ongoing fee is not reflected in the tables below. In a change from the proposal, we are modifying the first statement to provide that there is an implicit ongoing fee on index-linked options
to the extent
that an investor's participation in index gains is limited by the insurance company through the use of a cap, participation rate, or some other rate or measure.
186
In another change from the proposal, insurance companies will be required to provide both a statement to the effect that this implicit fee means that the investor's returns may be lower
than the index's returns and also a statement that the implicit fee is not reflected in the fee and cost tables. This disclosure replaces the proposed statement that the limit on index gains helps the insurance company generate a profit on the index-linked option, as we discuss in more detail later in this section of the release. As proposed, the disclosure will be required to precede the minimum and maximum fee table if the contract offers index-linked options and imposes ongoing fees and expenses.
186
See
final Form N-4, Instruction 2(c)(i)(G) to Item 3 (emphasis added);
see
proposed Form N-4, Instruction 2(c)(i)(G) to Item 3.
Also as proposed, in the case of a contract that offers an index-linked option subject to limits on gains but does not impose any explicit ongoing fees or expenses under the contract, the insurance company will include the disclosure
in lieu
of such tables.
187
That is, the disclosure will take the place of the fee and cost tables rather than precede them. Where there are no explicit ongoing fees, minimum and maximum annual fee and cost tables showing zero fees would tend to mislead investors because an index-linked option imposing limits on gains has implicit fees inherent in limiting upside index participation. The substance of the required disclosure will be largely the same as the disclosure discussed above but will not include the statement that the “implicit ongoing fee is not reflected in the tables below” since no tables will follow this disclosure.
188
187
See
final Form N-4, Instruction 2(c)(iii) to Item 3;
see
proposed Form N-4, Instruction 2(c)(iii) to Item 3.
188
See
final Form N-4, Instruction 2(c)(iii) to Item 3. The proposed disclosure in lieu of the tables was identical to the proposed disclosure preceding the tables.
See
proposed Form N-4, Instruction 2(c)(iii) to Item 3.
Lastly in this line item, we are adopting, as proposed, amendments revising the last sentence in the required legend in the lowest and highest annual cost table to include the italicized language: “This estimate assumes that you do not take withdrawals from the Contract, which could add surrender charges
and negative Contract Adjustments
that substantially increase costs.”
189
This will further alert investors to the cost impact of a contract adjustment if they withdraw money early.
189
See
final Form N-4, Instruction 2(c)(ii)(A) to Item 3. Currently, this legend only refers to surrender charges, not negative contract adjustments.
Commenters generally opposed one or more of the amendments to the Ongoing Fees and Expenses line item. One commenter expressed concerns that excluding disclosures of any ongoing fees that may be implicit to index-linked options in the KIT, but requiring variable options to disclose ongoing fees, could result in disparate treatment of these two types of annuities. Specifically, the commenter stated that this will produce unequal disclosure between the two products, which would not be appropriate in light of the similar profit margins to insurance companies generated by the fees.
190
The commenter did not suggest a specific alternative approach to quantify and disclose these implicit costs. We requested comment on whether it would be appropriate to develop a standardized methodology or calculation for accurately determining these costs.
191
Two commenters raised challenges with accurately determining these types of costs.
192
After considering comments regarding the challenges, we are not requiring numeric disclosure of implicit ongoing index-linked fees, but continue to welcome feedback from market participants and others on the feasibility of establishing a standardized approach to disclose these implicit fees.
190
See
VIP Working Group Comment Letter.
191
See, e.g.,
Proposing Release at request for comment number 48.
192
See
ACLI Comment Letter; CAI Comment Letter.
One commenter assumed the Commission intended that the lowest and highest annual cost table would only be disclosed in registration statements relating to variable options because the table's instructions reference “portfolio company fees and expenses,” which are relevant only to variable options.
193
The commenter therefore suggested that we amend the instructions to clarify that the table should be omitted if a prospectus is not offering variable options, and suggested that we not include references to “negative Contract Adjustments” in the legend preceding the table because variable options are not subject to contract adjustments. This table is not intended to be limited to variable options but rather applies to all investment options where ongoing fees are charged. While non-variable options sometimes do not have explicit ongoing fees, where ongoing fees are charged in connection with a non-variable option, they must be disclosed in this table. In addition, if the contract does not have a contract adjustment, insurance companies should revise the legend accordingly. Similarly, insurance companies would not include references to portfolio company fees and expenses in the minimum and maximum annual fee table and the assumptions in the lowest and highest annual cost table if the contract does not offer variable options.
193
See
CAI Comment Letter.
Some commenters opposed one or more of the required statements describing implicit fees.
194
Some of these commenters believed describing insurance company limits on the amount an investor can earn in a RILA as an “implicit ongoing fee” is inaccurate.
195
One commenter viewed such limits as factors that contribute to the pricing of RILA contracts.
196
Other commenters stated that these limits may not be triggered to actually limi
This text is long and has been trimmed here. Open the source document for the complete record.
This is a copy of a public record, reproduced as it was published. It is not legal advice, and it may not be the version a court would rely on. Check the official source before you cite it.